Timothy Rebbeck - Publications

Affiliations: 
University of Pennsylvania, Philadelphia, PA, United States 
Area:
Epidemiology

314 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Han D, Owiredu JN, Healy BM, Li M, Labaf M, Steinfeld JS, Patalano S, Gao S, Liu M, Macoska JA, Zarringhalam K, Siegfried KR, Yuan X, Rebbeck TR, Cai C. Susceptibility-associated genetic variation in NEDD9 contributes to prostate cancer initiation and progression. Cancer Research. PMID 33632899 DOI: 10.1158/0008-5472.CAN-20-3042  0.36
2021 Wang C, Zhang Z, Chong W, Luo R, Myers RE, Gu J, Lin J, Wei Q, Li B, Rebbeck TR, Lu-Yao G, Kelly WK, Yang H. Improved Prognostic Stratification Using Circulating Tumor Cell Clusters in Patients with Metastatic Castration-Resistant Prostate Cancer. Cancers. 13. PMID 33450815 DOI: 10.3390/cancers13020268  0.48
2020 Tegally H, Kensler KH, Mungloo-Dilmohamud Z, Ghoorah AW, Rebbeck TR, Baichoo S. Discovering novel driver mutations from pan-cancer analysis of mutational and gene expression profiles. Plos One. 15: e0242780. PMID 33232371 DOI: 10.1371/journal.pone.0242780  0.4
2020 Kensler KH, Pernar CH, Mahal BA, Nguyen PL, Trinh QD, Kibel AS, Rebbeck TR. Racial/ethnic variation in PSA testing and prostate cancer incidence following the 2012 U.S.P.S.T.F. recommendation. Journal of the National Cancer Institute. PMID 33146392 DOI: 10.1093/jnci/djaa171  0.4
2020 Glubb DM, Thompson DJ, Aben KK, Alsulimani A, Amant F, Annibali D, Attia J, Barricarte A, Beckmann MW, Berchuck A, Bermisheva M, Bernardini MQ, Bischof K, Bjørge L, Bodelon C, ... ... Rebbeck TR, et al. Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 33144283 DOI: 10.1158/1055-9965.EPI-20-0739  0.32
2020 Awasthi S, Berglund AE, Abraham-Miranda J, Rounbehler RJ, Kensler KH, Serna AN, Vidal AC, You S, Freeman MR, Davicioni E, Liu Y, Karnes JR, Klein EA, Den RB, Trock BJ, ... ... Rebbeck TR, et al. Comparative genomics reveals distinct immune-oncologic pathways in African American men with prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33037017 DOI: 10.1158/1078-0432.CCR-20-2925  0.4
2020 Mahal BA, Alshalalfa M, Kensler KH, Chowdhury-Paulino I, Kantoff P, Mucci LA, Schaeffer EM, Spratt D, Yamoah K, Nguyen PL, Rebbeck TR. Racial Differences in Genomic Profiling of Prostate Cancer. The New England Journal of Medicine. 383: 1083-1085. PMID 32905685 DOI: 10.1056/Nejmc2000069  0.4
2020 Chen J, Bae E, Zhang L, Hughes K, Parmigiani G, Braun D, Rebbeck TR. Penetrance of Breast and Ovarian Cancer in Women Who Carry a Mutation and Do Not Use Risk-Reducing Salpingo-Oophorectomy: An Updated Meta-Analysis. Jnci Cancer Spectrum. 4: pkaa029. PMID 32676552 DOI: 10.1093/jncics/pkaa029  0.52
2020 Silvestri V, Leslie G, Barnes DR, Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Barkardottir RB, Barroso A, Barrowdale D, Benitez J, Bonanni B, Borg A, Buys SS, ... ... Rebbeck TR, et al. Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Jama Oncology. PMID 32614418 DOI: 10.1001/Jamaoncol.2020.2134  0.48
2020 Giri VN, Knudsen KE, Kelly WK, Cheng HH, Cooney KA, Cookson MS, Dahut W, Weissman S, Soule HR, Petrylak DP, Dicker AP, AlDubayan SH, Toland AE, Pritchard CC, Pettaway CA, ... ... Rebbeck TR, et al. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2000046. PMID 32516092 DOI: 10.1200/Jco.20.00046  0.48
2020 Yuan J, Kensler KH, Hu Z, Zhang Y, Zhang T, Jiang J, Xu M, Pan Y, Long M, Montone KT, Tanyi JL, Fan Y, Zhang R, Hu X, Rebbeck TR, et al. Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry. Plos Genetics. 16: e1008641. PMID 32059012 DOI: 10.1371/journal.pgen.1008641  0.64
2020 Tan XL, E JY, Lin Y, Rebbeck TR, Lu SE, Shang M, Kelly WK, D'Amico A, Stein MN, Zhang L, Jang TL, Kim IY, Demissie K, Ferrari A, Lu-Yao G. Individual and joint effects of metformin and statins on mortality among patients with high-risk prostate cancer. Cancer Medicine. PMID 32035002 DOI: 10.1002/Cam4.2862  0.48
2020 Kensler KH, Rebbeck TR. Cancer Progress and Priorities: Prostate Cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 29: 267-277. PMID 32024765 DOI: 10.1158/1055-9965.EPI-19-0412  0.4
2020 Solsky I, Chen J, Rebbeck TR. Precision prophylaxis: Identifying the optimal timing for risk-reducing salpingo-oophorectomy based on type of BRCA1 and BRCA2 cluster region mutations. Gynecologic Oncology. PMID 31918993 DOI: 10.1016/j.ygyno.2019.11.036  0.52
2019 Patel VL, Busch EL, Friebel TM, Cronin A, Leslie G, McGuffog L, Adlard J, Agata S, Agnarsson BA, Ahmed M, Aittomäki K, Alducci E, Andrulis IL, Arason A, Arnold N, ... ... Rebbeck TR, et al. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness. Cancer Research. PMID 31723001 DOI: 10.1158/0008-5472.Can-19-1840  0.48
2019 Lu-Yao G, Nikita N, Keith SW, Nightingale G, Gandhi K, Hegarty SE, Rebbeck TR, Chapman A, Kantoff PW, Cullen J, Gomella L, Kelly WK. Mortality and Hospitalization Risk Following Oral Androgen Signaling Inhibitors Among Men with Advanced Prostate Cancer by Pre-existing Cardiovascular Comorbidities. European Urology. PMID 31420248 DOI: 10.1016/J.Eururo.2019.07.031  0.48
2019 Friebel TM, Andrulis IL, Balmaña J, Blanco AM, Couch FJ, Daly MB, Domchek SM, Easton DF, Foulkes WD, Ganz PA, Garber J, Glendon G, Greene MH, Hulick PJ, Isaacs C, ... ... Rebbeck TR, et al. BRCA1 and BRCA2 Pathogenic Sequence Variants in Women of African Origin or Ancestry. Human Mutation. PMID 31112363 DOI: 10.1002/Humu.23804  0.48
2019 Campbell PT, Ambrosone CB, Nishihara R, Aerts HJWL, Bondy M, Chatterjee N, Garcia-Closas M, Giannakis M, Golden JA, Heng YJ, Kip NS, Koshiol J, Liu XS, Lopes-Ramos CM, Mucci LA, ... ... Rebbeck TR, et al. Proceedings of the fourth international molecular pathological epidemiology (MPE) meeting. Cancer Causes & Control : Ccc. PMID 31069578 DOI: 10.1007/s10552-019-01177-z  0.48
2018 Zhao H, Mitra N, Kanetsky PA, Nathanson KL, Rebbeck TR. A practical approach to adjusting for population stratification in genome-wide association studies: principal components and propensity scores (PCAPS). Statistical Applications in Genetics and Molecular Biology. PMID 30507552 DOI: 10.1515/Sagmb-2017-0054  0.76
2018 Qian F, Wang S, Mitchell J, McGuffog L, Barrowdale D, Leslie G, Oosterwijk JC, Chung WK, Evans DG, Engel C, Kast K, Aalfs CM, Adank MA, Adlard J, Agnarsson BA, ... ... Rebbeck TR, et al. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study. Journal of the National Cancer Institute. PMID 30312457 DOI: 10.1093/jnci/djy132  0.48
2018 Yuan J, Hu Z, Mahal BA, Zhao SD, Kensler KH, Pi J, Hu X, Zhang Y, Wang Y, Jiang J, Li C, Zhong X, Montone KT, Guan G, Tanyi JL, ... ... Rebbeck TR, et al. Integrated Analysis of Genetic Ancestry and Genomic Alterations across Cancers. Cancer Cell. 34: 549-560.e9. PMID 30300578 DOI: 10.1016/J.Ccell.2018.08.019  0.64
2018 Rebbeck TR, Burns-White K, Chan AT, Emmons K, Freedman M, Hunter DJ, Kraft P, Laden F, Mucci L, Parmigiani G, Schrag D, Syngal S, Tamimi RM, Viswanath K, Yurgelun MB, et al. Precision Prevention and Early Detection of Cancer: Fundamental Principles. Cancer Discovery. PMID 29907587 DOI: 10.1158/2159-8290.Cd-17-1415  0.32
2018 Zhang L, Shin VY, Chai X, Zhang A, Chan TL, Ma ES, Rebbeck TR, Chen J, Kwong A. Breast and ovarian cancer penetrance of mutations among Hong Kong women. Oncotarget. 9: 25025-25033. PMID 29861850 DOI: 10.18632/oncotarget.24382  0.52
2018 Rebbeck TR, Friebel TM, Friedman E, Hamann U, Huo D, Kwong A, Olah E, Olopade OI, Solano AR, Teo SH, Thomassen M, Weitzel JN, Chan TL, Couch FJ, Goldgar DE, et al. Mutational Spectrum in a Worldwide Study of 29,700 Families with BRCA1 or BRCA2 Mutations. Human Mutation. PMID 29446198 DOI: 10.1002/Humu.23406  0.48
2017 Giri VN, Knudsen KE, Kelly WK, Abida W, Andriole GL, Bangma CH, Bekelman JE, Benson MC, Blanco A, Burnett A, Catalona WJ, Cooney KA, Cooperberg M, Crawford DE, Den RB, ... ... Rebbeck TR, et al. Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017741173. PMID 29236593 DOI: 10.1200/Jco.2017.74.1173  0.48
2017 Lynch SM, Mitra N, Ravichandran K, Mitchell J, Spangler E, Zhou W, Paskett ED, Gehlert S, DeGraffinreid C, Stowe R, Dubowitz T, Riethman H, Branas CC, Peek MK, Rebbeck TR. Telomere Length and Neighborhood Circumstances: Evaluating Biological Response to Unfavorable Exposures. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 26: 553-560. PMID 28373169 DOI: 10.1158/1055-9965.Epi-16-0554  0.76
2017 Lynch SM, Mitra N, Ross M, Newcomb C, Dailey K, Jackson T, Zeigler-Johnson CM, Riethman H, Branas CC, Rebbeck TR. A Neighborhood-Wide Association Study (NWAS): Example of prostate cancer aggressiveness. Plos One. 12: e0174548. PMID 28346484 DOI: 10.1371/Journal.Pone.0174548  0.76
2017 Campbell PT, Rebbeck TR, Nishihara R, Beck AH, Begg CB, Bogdanov AA, Cao Y, Coleman HG, Freeman GJ, Heng YJ, Huttenhower C, Irizarry RA, Kip NS, Michor F, Nevo D, et al. Proceedings of the third international molecular pathological epidemiology (MPE) meeting. Cancer Causes & Control : Ccc. PMID 28097472 DOI: 10.1007/s10552-016-0845-z  0.48
2016 Rebbeck TR, Friebel TM, Mitra N, Wan F, Chen S, Andrulis IL, Apostolou P, Arnold N, Arun BK, Barrowdale D, Benitez J, Berger R, Berthet P, Borg A, Buys SS, et al. Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women. Breast Cancer Research : Bcr. 18: 112. PMID 27836010 DOI: 10.1186/S13058-016-0768-3  0.76
2016 Spira A, Disis ML, Schiller JT, Vilar E, Rebbeck TR, Bejar R, Ideker T, Arts J, Yurgelun MB, Mesirov JP, Rao A, Garber J, Jaffee EM, Lippman SM. Leveraging premalignant biology for immune-based cancer prevention. Proceedings of the National Academy of Sciences of the United States of America. PMID 27638202 DOI: 10.1073/Pnas.1608077113  0.76
2016 Yamoah K, Zeigler-Johnson CM, Jeffers A, Malkowicz B, Spangler E, Park JY, Whittemore A, Rebbeck TR. The impact of body mass index on treatment outcomes for patients with low-intermediate risk prostate cancer. Bmc Cancer. 16: 557. PMID 27473687 DOI: 10.1186/S12885-016-2572-Y  0.44
2016 Silvestri V, Barrowdale D, Mulligan AM, Neuhausen SL, Fox S, Karlan BY, Mitchell G, James P, Thull DL, Zorn KK, Carter NJ, Nathanson KL, Domchek SM, Rebbeck TR, Ramus SJ, et al. Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Research : Bcr. 18: 15. PMID 26857456 DOI: 10.1186/S13058-016-0671-Y  0.76
2016 Lynch SM, Peek MK, Mitra N, Ravichandran K, Branas C, Spangler E, Zhou W, Paskett ED, Gehlert S, DeGraffinreid C, Rebbeck TR, Riethman H. Race, Ethnicity, Psychosocial Factors, and Telomere Length in a Multicenter Setting. Plos One. 11: e0146723. PMID 26752285 DOI: 10.1371/Journal.Pone.0146723  0.76
2016 Scales R, Spangler E, Morales K, Glanz K, Rebbeck T, Zeigler-Johnson C. Abstract A71: Modification of obesity associations with prostate cancer grade by area-level factors Cancer Epidemiology, Biomarkers & Prevention. 25. DOI: 10.1158/1538-7755.Disp15-A71  0.44
2016 Lynch S, Mitra N, Ross M, Newcomb C, Daily K, Jackson T, Zeigler-Johnson C, Riethman H, Branas C, Rebbeck T. Abstract 4351: A neighborhood-wide association study (NWAS) in prostate cancer: A new methodologic approach Cancer Research. 76: 4351-4351. DOI: 10.1158/1538-7445.Am2016-4351  0.76
2015 Banerjee S, Wei Z, Tan F, Peck KN, Shih N, Feldman M, Rebbeck TR, Alwine JC, Robertson ES. Distinct microbiological signatures associated with triple negative breast cancer. Scientific Reports. 5: 15162. PMID 26469225 DOI: 10.1038/Srep15162  0.76
2015 Yan X, Hu Z, Feng Y, Hu X, Yuan J, Zhao SD, Zhang Y, Yang L, Shan W, He Q, Fan L, Kandalaft LE, Tanyi JL, Li C, Yuan CX, ... ... Rebbeck T, et al. Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers. Cancer Cell. 28: 529-40. PMID 26461095 DOI: 10.1016/J.Ccell.2015.09.006  0.76
2015 Nan H, Dorgan JF, Rebbeck TR. Genetic variants in hypothalamic-pituitary-adrenal axis genes and breast cancer risk in Caucasians and African Americans. International Journal of Molecular Epidemiology and Genetics. 6: 33-40. PMID 26417403  0.76
2015 Dryden-Peterson S, Medhin H, Kebabonye-Pusoentsi M, Seage GR, Suneja G, Kayembe MK, Mmalane M, Rebbeck T, Rider JR, Essex M, Lockman S. Cancer Incidence following Expansion of HIV Treatment in Botswana. Plos One. 10: e0135602. PMID 26267867 DOI: 10.1371/Journal.Pone.0135602  0.76
2015 Chai X, Domchek S, Kauff N, Rebbeck T, Chen J. RE: Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction. Journal of the National Cancer Institute. 107. PMID 26264690 DOI: 10.1093/Jnci/Djv033  0.76
2015 Yamoah K, Johnson MH, Choeurng V, Faisal FA, Yousefi K, Haddad Z, Ross AE, Alshalafa M, Den R, Lal P, Feldman M, Dicker AP, Klein EA, Davicioni E, Rebbeck TR, et al. Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26195723 DOI: 10.1200/Jco.2014.59.8912  0.76
2015 Zeigler-Johnson C, Morales KH, Glanz K, Spangler E, Mitchell J, Rebbeck TR. Individual- and neighborhood-level education influences the effect of obesity on prostate cancer treatment failure after prostatectomy. Cancer Causes & Control : Ccc. PMID 26169299 DOI: 10.1007/s10552-015-0628-y  0.76
2015 Rebbeck TR, Mitra N, Wan F, Sinilnikova OM, Healey S, McGuffog L, Mazoyer S, Chenevix-Trench G, Easton DF, Antoniou AC, Nathanson KL, Laitman Y, Kushnir A, Paluch-Shimon S, et al. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. Jama. 313: 1347-61. PMID 25849179 DOI: 10.1001/Jama.2014.5985  0.76
2015 Amin Al Olama A, Benlloch S, Antoniou AC, Giles GG, Severi G, Neal DE, Hamdy FC, Donovan JL, Muir K, Schleutker J, Henderson BE, Haiman CA, Schumacher FR, Pashayan N, Pharoah PD, ... ... Rebbeck TR, et al. Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 1121-9. PMID 25837820 DOI: 10.1158/1055-9965.Epi-14-0317  0.76
2015 Blanco I, Kuchenbaecker K, Cuadras D, Wang X, Barrowdale D, de Garibay GR, Librado P, Sánchez-Gracia A, Rozas J, Bonifaci N, McGuffog L, Pankratz VS, Islam A, Mateo F, Berenguer A, ... ... Rebbeck TR, et al. Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers. Plos One. 10: e0120020. PMID 25830658 DOI: 10.1371/Journal.Pone.0120020  0.76
2015 Taylor NJ, Busam KJ, From L, Groben PA, Anton-Culver H, Cust AE, Begg CB, Dwyer T, Gallagher RP, Gruber SB, Orlow I, Rosso S, Thomas NE, Zanetti R, Rebbeck TR, et al. Inherited variation at MC1R and histological characteristics of primary melanoma. Plos One. 10: e0119920. PMID 25790105 DOI: 10.1371/Journal.Pone.0119920  0.76
2015 Helfand BT, Roehl KA, Cooper PR, McGuire BB, Fitzgerald LM, Cancel-Tassin G, Cornu JN, Bauer S, Van Blarigan EL, Chen X, Duggan D, Ostrander EA, Gwo-Shu M, Zhang ZF, Chang SC, ... ... Rebbeck TR, et al. Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases. Human Genetics. 134: 439-50. PMID 25715684 DOI: 10.1007/S00439-015-1534-9  0.76
2015 Davies JR, Chang YM, Bishop DT, Armstrong BK, Bataille V, Bergman W, Berwick M, Bracci PM, Elwood JM, Ernstoff MS, Green A, Gruis NA, Holly EA, Ingvar C, Kanetsky PA, ... ... Rebbeck TR, et al. Development and validation of a melanoma risk score based on pooled data from 16 case-control studies. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 817-24. PMID 25713022 DOI: 10.1158/1055-9965.Epi-14-1062  0.76
2015 Cote ML, Alhajj T, Ruterbusch JJ, Bernstein L, Brinton LA, Blot WJ, Chen C, Gass M, Gaussoin S, Henderson B, Lee E, Horn-Ross PL, Kolonel LN, Kaunitz A, Liang X, ... ... Rebbeck TR, et al. Risk factors for endometrial cancer in black and white women: a pooled analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2). Cancer Causes & Control : Ccc. 26: 287-96. PMID 25534916 DOI: 10.1007/S10552-014-0510-3  0.76
2015 Yamoah K, Walker A, Spangler E, Zeigler-Johnson CM, Malkowicz B, Lee DI, Dicker AP, Rebbeck TR, Lal P. African-american race is a predictor of seminal vesicle invasion after radical prostatectomy. Clinical Genitourinary Cancer. 13: e65-72. PMID 25450037 DOI: 10.1016/j.clgc.2014.08.012  0.76
2015 Taylor NJ, Reiner AS, Begg CB, Cust AE, Busam KJ, Anton-Culver H, Dwyer T, From L, Gallagher RP, Gruber SB, Rosso S, White KA, Zanetti R, Orlow I, Thomas NE, ... Rebbeck TR, et al. Inherited variation at MC1R and ASIP and association with melanoma-specific survival. International Journal of Cancer. Journal International Du Cancer. 136: 2659-67. PMID 25382380 DOI: 10.1002/Ijc.29317  0.76
2015 Peterlongo P, Chang-Claude J, Moysich KB, Rudolph A, Schmutzler RK, Simard J, Soucy P, Eeles RA, Easton DF, Hamann U, Wilkening S, Chen B, Rookus MA, Schmidt MK, van der Baan FH, ... ... Rebbeck TR, et al. Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 308-16. PMID 25336561 DOI: 10.1158/1055-9965.Epi-14-0532  0.76
2015 Yamoah K, Deville C, Vapiwala N, Spangler E, Zeigler-Johnson CM, Malkowicz B, Lee DI, Kattan M, Dicker AP, Rebbeck TR. African American men with low-grade prostate cancer have increased disease recurrence after prostatectomy compared with Caucasian men. Urologic Oncology. 33: 70.e15-22. PMID 25304288 DOI: 10.1016/J.Urolonc.2014.07.005  0.76
2015 Lee G, Singanamalli A, Wang H, Feldman MD, Master SR, Shih NN, Spangler E, Rebbeck T, Tomaszewski JE, Madabhushi A. Supervised multi-view canonical correlation analysis (sMVCCA): integrating histologic and proteomic features for predicting recurrent prostate cancer. Ieee Transactions On Medical Imaging. 34: 284-97. PMID 25203987 DOI: 10.1109/Tmi.2014.2355175  0.76
2015 Han Y, Signorello LB, Strom SS, Kittles RA, Rybicki BA, Stanford JL, Goodman PJ, Berndt SI, Carpten J, Casey G, Chu L, Conti DV, Rand KA, Diver WR, Hennis AJ, ... ... Rebbeck TR, et al. Generalizability of established prostate cancer risk variants in men of African ancestry. International Journal of Cancer. Journal International Du Cancer. 136: 1210-7. PMID 25044450 DOI: 10.1002/Ijc.29066  0.76
2015 Zeigler-Johnson CM, Morales K, Mitchell J, Spangler E, Glanz K, Rebbeck T. Abstract 3722: Modification of obesity effects on prostate cancer outcomes by age and education Cancer Research. 75: 3722-3722. DOI: 10.1158/1538-7445.Am2015-3722  0.44
2015 Spangler E, Zeigler-Johnson C, Mitchell J, Rebbeck T. Abstract 3720: Diabetes and prostate cancer (CaP): Clinical characteristics and disparity in outcomes Cancer Research. 75: 3720-3720. DOI: 10.1158/1538-7445.Am2015-3720  0.44
2015 Dryden-Peterson S, Medhin H, Kebabonye-Pusoentsi M, Seage GR, Suneja G, Kayembe MKA, Mmalane M, Rebbeck T, Rider JR, Essex M, Lockman S. Correction: Cancer incidence following expansion of HIV treatment in Botswana (PLoS ONE (2015) 10:9 (PLoS ONE) DOI:10.1371/journal.pone.0138742) Plos One. 10.  0.76
2014 Kuchenbaecker KB, Neuhausen SL, Robson M, Barrowdale D, McGuffog L, Mulligan AM, Andrulis IL, Spurdle AB, Schmidt MK, Schmutzler RK, Engel C, Wappenschmidt B, Nevanlinna H, Thomassen M, Southey M, ... ... Rebbeck TR, et al. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research : Bcr. 16: 3416. PMID 25919761 DOI: 10.1186/S13058-014-0492-9  0.76
2014 Spurdle AB, Couch FJ, Parsons MT, McGuffog L, Barrowdale D, Bolla MK, Wang Q, Healey S, Schmutzler R, Wappenschmidt B, Rhiem K, Hahnen E, Engel C, Meindl A, Ditsch N, ... ... Rebbeck TR, et al. Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia. Breast Cancer Research : Bcr. 16: 3419. PMID 25857409 DOI: 10.1186/S13058-014-0474-Y  0.76
2014 Nan H, Dorgan JF, Rebbeck TR. Genetic variants in anti-Mullerian hormone and anti-Mullerian hormone receptor genes and breast cancer risk in Caucasians and African Americans. International Journal of Molecular Epidemiology and Genetics. 5: 145-51. PMID 25379134  0.76
2014 Rebbeck TR. Precision prevention of cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 2713-5. PMID 25362191 DOI: 10.1158/1055-9965.EPI-14-1058  0.76
2014 Rebbeck TR, Haas GP. Temporal trends and racial disparities in global prostate cancer prevalence. The Canadian Journal of Urology. 21: 7496-506. PMID 25347377  0.76
2014 Chai X, Friebel TM, Singer CF, Evans DG, Lynch HT, Isaacs C, Garber JE, Neuhausen SL, Matloff E, Eeles R, Tung N, Weitzel JN, Couch FJ, Hulick PJ, Ganz PA, ... ... Rebbeck TR, et al. Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment. 148: 397-406. PMID 25311111 DOI: 10.1007/S10549-014-3134-0  0.76
2014 Arteaga CL, Adamson PC, Engelman JA, Foti M, Gaynor RB, Hilsenbeck SG, Limburg PJ, Lowe SW, Mardis ER, Ramsey S, Rebbeck TR, Richardson AL, Rubin EH, Weiner GJ. AACR Cancer Progress Report 2014. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: S1-S112. PMID 25228531 DOI: 10.1158/1078-0432.Ccr-14-2123  0.76
2014 Lee JV, Carrer A, Shah S, Snyder NW, Wei S, Venneti S, Worth AJ, Yuan ZF, Lim HW, Liu S, Jackson E, Aiello NM, Haas NB, Rebbeck TR, Judkins A, et al. Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation. Cell Metabolism. 20: 306-19. PMID 24998913 DOI: 10.1016/J.Cmet.2014.06.004  0.76
2014 Rosenstein BS, West CM, Bentzen SM, Alsner J, Andreassen CN, Azria D, Barnett GC, Baumann M, Burnet N, Chang-Claude J, Chuang EY, Coles CE, Dekker A, De Ruyck K, De Ruysscher D, ... ... Rebbeck TR, et al. Radiogenomics: radiobiology enters the era of big data and team science. International Journal of Radiation Oncology, Biology, Physics. 89: 709-13. PMID 24969789 DOI: 10.1016/J.Ijrobp.2014.03.009  0.76
2014 Lee G, Sparks R, Ali S, Shih NN, Feldman MD, Spangler E, Rebbeck T, Tomaszewski JE, Madabhushi A. Co-occurring gland angularity in localized subgraphs: predicting biochemical recurrence in intermediate-risk prostate cancer patients. Plos One. 9: e97954. PMID 24875018 DOI: 10.1371/Journal.Pone.0097954  0.76
2014 Friebel TM, Domchek SM, Rebbeck TR. Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis. Journal of the National Cancer Institute. 106: dju091. PMID 24824314 DOI: 10.1093/jnci/dju091  0.76
2014 Rebbeck TR. Academic bigotry. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1445-6. PMID 24813817 DOI: 10.1158/1055-9965.EPI-14-0500  0.76
2014 Chen MM, Crous-Bou M, Setiawan VW, Prescott J, Olson SH, Wentzensen N, Black A, Brinton L, Chen C, Chen C, Cook LS, Doherty J, Friedenreich CM, Hankinson SE, Hartge P, ... ... Rebbeck TR, et al. Exome-wide association study of endometrial cancer in a multiethnic population. Plos One. 9: e97045. PMID 24810602 DOI: 10.1371/Journal.Pone.0097045  0.76
2014 Neslund-Dudas C, Levin AM, Beebe-Dimmer JL, Bock CH, Nock NL, Rundle A, Jankowski M, Krajenta R, Dou QP, Mitra B, Tang D, Rebbeck TR, Rybicki BA. Gene-environment interactions between JAZF1 and occupational and household lead exposure in prostate cancer among African American men. Cancer Causes & Control : Ccc. 25: 869-79. PMID 24801046 DOI: 10.1007/S10552-014-0387-1  0.76
2014 Osorio A, Milne RL, Kuchenbaecker K, Vaclová T, Pita G, Alonso R, Peterlongo P, Blanco I, de la Hoya M, Duran M, Díez O, Ramón Y Cajal T, Konstantopoulou I, Martínez-Bouzas C, Andrés Conejero R, ... ... Rebbeck TR, et al. DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers. Plos Genetics. 10: e1004256. PMID 24698998 DOI: 10.1371/Journal.Pgen.1004256  0.76
2014 Adewole I, Martin DN, Williams MJ, Adebamowo C, Bhatia K, Berling C, Casper C, Elshamy K, Elzawawy A, Lawlor RT, Legood R, Mbulaiteye SM, Odedina FT, Olopade OI, Olopade CO, ... ... Rebbeck TR, et al. Building capacity for sustainable research programmes for cancer in Africa. Nature Reviews. Clinical Oncology. 11: 251-9. PMID 24614139 DOI: 10.1038/Nrclinonc.2014.37  0.76
2014 Margolis DJ, Gupta J, Apter AJ, Hoffstad O, Papadopoulos M, Rebbeck TR, Wubbenhorst B, Mitra N. Exome sequencing of filaggrin and related genes in African-American children with atopic dermatitis. The Journal of Investigative Dermatology. 134: 2272-4. PMID 24608987 DOI: 10.1038/Jid.2014.126  0.76
2014 Butts SF, Sammel MD, Greer C, Rebbeck TR, Boorman DW, Freeman EW. Cigarettes, genetic background, and menopausal timing: the presence of single nucleotide polymorphisms in cytochrome P450 genes is associated with increased risk of natural menopause in European-American smokers. Menopause (New York, N.Y.). 21: 694-701. PMID 24448104 DOI: 10.1097/Gme.0000000000000140  0.76
2014 Margolis DJ, Gupta J, Apter AJ, Ganguly T, Hoffstad O, Papadopoulos M, Rebbeck TR, Mitra N. Filaggrin-2 variation is associated with more persistent atopic dermatitis in African American subjects. The Journal of Allergy and Clinical Immunology. 133: 784-9. PMID 24184149 DOI: 10.1016/J.Jaci.2013.09.015  0.76
2014 De Vivo I, Prescott J, Setiawan VW, Olson SH, Wentzensen N, Attia J, Black A, Brinton L, Chen C, Chen C, Cook LS, Crous-Bou M, Doherty J, Dunning AM, ... ... Rebbeck TR, et al. Genome-wide association study of endometrial cancer in E2C2. Human Genetics. 133: 211-24. PMID 24096698 DOI: 10.1007/S00439-013-1369-1  0.76
2014 Rebbeck TR. The next twenty years: Predicting and preparing for the future cancer landscape in Sub-Saharan Africa Journal Africain Du Cancer / African Journal of Cancer. DOI: 10.1007/s12558-014-0331-z  0.76
2013 Zeigler-Johnson C, Weber A, Glanz K, Spangler E, Rebbeck TR. Gender- and ethnic-specific associations with obesity: individual and neighborhood-level factors. Journal of the National Medical Association. 105: 173-82. PMID 24079218  0.76
2013 Hughes L, Ruth K, Rebbeck TR, Giri VN. Genetic variation in IL-16 miRNA target site and time to prostate cancer diagnosis in African-American men. Prostate Cancer and Prostatic Diseases. 16: 308-14. PMID 24061634 DOI: 10.1038/pcan.2013.36  0.76
2013 Gabriel CA, Mitra N, Demichele A, Rebbeck T. Association of progesterone receptor gene (PGR) variants and breast cancer risk in African American women. Breast Cancer Research and Treatment. 139: 833-43. PMID 23764995 DOI: 10.1007/S10549-013-2592-0  0.76
2013 Setiawan VW, Yang HP, Pike MC, McCann SE, Yu H, Xiang YB, Wolk A, Wentzensen N, Weiss NS, Webb PM, van den Brandt PA, van de Vijver K, Thompson PJ, Strom BL, ... ... Rebbeck TR, et al. Type I and II endometrial cancers: have they different risk factors? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 2607-18. PMID 23733771 DOI: 10.1200/Jco.2012.48.2596  0.76
2013 Adesina A, Chumba D, Nelson AM, Orem J, Roberts DJ, Wabinga H, Wilson M, Rebbeck TR. Improvement of pathology in sub-Saharan Africa. The Lancet. Oncology. 14: e152-7. PMID 23561746 DOI: 10.1016/S1470-2045(12)70598-3  0.76
2013 Morhason-Bello IO, Odedina F, Rebbeck TR, Harford J, Dangou JM, Denny L, Adewole IF. Challenges and opportunities in cancer control in Africa: a perspective from the African Organisation for Research and Training in Cancer. The Lancet. Oncology. 14: e142-51. PMID 23561745 DOI: 10.1016/S1470-2045(12)70482-5  0.76
2013 Zeigler-Johnson C, Morales KH, Spangler E, Chang BL, Rebbeck TR. Relationship of early-onset baldness to prostate cancer in African-American men. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 589-96. PMID 23532004 DOI: 10.1158/1055-9965.EPI-12-0944  0.76
2013 Rebbeck TR, Devesa SS, Chang BL, Bunker CH, Cheng I, Cooney K, Eeles R, Fernandez P, Giri VN, Gueye SM, Haiman CA, Henderson BE, Heyns CF, Hu JJ, Ingles SA, et al. Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent. Prostate Cancer. 2013: 560857. PMID 23476788 DOI: 10.1155/2013/560857  0.44
2013 Zheng Y, Ogundiran TO, Falusi AG, Nathanson KL, John EM, Hennis AJ, Ambs S, Domchek SM, Rebbeck TR, Simon MS, Nemesure B, Wu SY, Leske MC, Odetunde A, Niu Q, et al. Fine mapping of breast cancer genome-wide association studies loci in women of African ancestry identifies novel susceptibility markers. Carcinogenesis. 34: 1520-8. PMID 23475944 DOI: 10.1093/Carcin/Bgt090  0.76
2013 Lynch SM, Rebbeck TR. Bridging the gap between biologic, individual, and macroenvironmental factors in cancer: a multilevel approach. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 485-95. PMID 23462925 DOI: 10.1158/1055-9965.EPI-13-0010  0.76
2013 Khoury MJ, Lam TK, Ioannidis JP, Hartge P, Spitz MR, Buring JE, Chanock SJ, Croyle RT, Goddard KA, Ginsburg GS, Herceg Z, Hiatt RA, Hoover RN, Hunter DJ, Kramer BS, ... ... Rebbeck TR, et al. Transforming epidemiology for 21st century medicine and public health. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 508-16. PMID 23462917 DOI: 10.1158/1055-9965.Epi-13-0146  0.76
2013 Mitchell JA, Hakonarson H, Rebbeck TR, Grant SF. Obesity-susceptibility loci and the tails of the pediatric BMI distribution. Obesity (Silver Spring, Md.). 21: 1256-60. PMID 23408508 DOI: 10.1002/Oby.20319  0.76
2013 Rebbeck TR, Weber AL, Spangler E, Zeigler-Johnson CM. What stresses men? Predictors of perceived stress in a population-based multi-ethnic cross sectional cohort. Bmc Public Health. 13: 113. PMID 23388399 DOI: 10.1186/1471-2458-13-113  0.76
2013 Jalloh M, Friebel TM, Sira Thiam F, Niang L, Sy C, Siby T, Fernandez P, Mapulanga V, Maina S, Doodu Mante S, Yeboah E, Kyei M, Ankomah R, Amegbor J, Adusei B, ... ... Rebbeck TR, et al. Evaluation of 4, 672 routine prostate biopsies performed in six African countries Journal Africain Du Cancer. 5: 144-154. DOI: 10.1007/S12558-013-0264-Y  0.76
2012 Zhao H, Rebbeck TR, Mitra N. Analyzing genetic association studies with an extended propensity score approach. Statistical Applications in Genetics and Molecular Biology. 11. PMID 23104843 DOI: 10.1515/1544-6115.1790  0.76
2012 Fernandez P, Zeigler-Johnson CM, Spangler E, van der Merwe A, Jalloh M, Gueye SM, Rebbeck TR. Androgen Metabolism Gene Polymorphisms, Associations with Prostate Cancer Risk and Pathological Characteristics: A Comparative Analysis between South African and Senegalese Men. Prostate Cancer. 2012: 798634. PMID 23091730 DOI: 10.1155/2012/798634  0.44
2012 Stevens KN, Wang X, Fredericksen Z, Pankratz VS, Greene MH, Andrulis IL, Thomassen M, Caligo M, Nathanson KL, Jakubowska A, Osorio A, Hamann U, Godwin AK, Stoppa-Lyonnet D, ... ... Rebbeck TR, et al. Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers. Breast Cancer Research and Treatment. 136: 295-302. PMID 23011509 DOI: 10.1007/S10549-012-2255-6  0.76
2012 Braithwaite D, Boffetta P, Rebbeck TR, Meyskens F. Cancer prevention for global health: a report from the ASPO International Cancer Prevention Interest Group. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 1606-10. PMID 22850804 DOI: 10.1158/1055-9965.Epi-12-0848  0.76
2012 Lachance J, Vernot B, Elbers CC, Ferwerda B, Froment A, Bodo JM, Lema G, Fu W, Nyambo TB, Rebbeck TR, Zhang K, Akey JM, Tishkoff SA. Evolutionary history and adaptation from high-coverage whole-genome sequences of diverse African hunter-gatherers. Cell. 150: 457-69. PMID 22840920 DOI: 10.1016/J.Cell.2012.07.009  0.76
2012 Ding YC, McGuffog L, Healey S, Friedman E, Laitman Y, Paluch-Shimon S, Kaufman B, Liljegren A, Lindblom A, Olsson H, Kristoffersson U, Stenmark-Askmalm M, Melin B, Domchek SM, ... ... Rebbeck TR, et al. A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 1362-70. PMID 22729394 DOI: 10.1158/1055-9965.Epi-12-0229  0.76
2012 Butts SF, Freeman EW, Sammel MD, Queen K, Lin H, Rebbeck TR. Joint effects of smoking and gene variants involved in sex steroid metabolism on hot flashes in late reproductive-age women. The Journal of Clinical Endocrinology and Metabolism. 97: E1032-42. PMID 22466345 DOI: 10.1210/Jc.2011-2216  0.76
2012 Finkelman BS, Rubinstein WS, Friedman S, Friebel TM, Dubitsky S, Schonberger NS, Shoretz R, Singer CF, Blum JL, Tung N, Olopade OI, Weitzel JN, Lynch HT, Snyder C, Garber JE, ... ... Rebbeck TR, et al. Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 1321-8. PMID 22430266 DOI: 10.1200/Jco.2011.37.8133  0.76
2012 Roberts DJ, Wilson ML, Nelson AM, Adesina AM, Fleming KA, Milner D, Guarner J, Rebbeck TR, Castle P, Lucas S. The good news about cancer in developing countries--pathology answers the call. Lancet. 379: 712. PMID 22364759 DOI: 10.1016/S0140-6736(12)60306-7  0.76
2012 Couch FJ, Gaudet MM, Antoniou AC, Ramus SJ, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, Wang X, Kirchhoff T, McGuffog L, Barrowdale D, Lee A, Healey S, Sinilnikova OM, ... ... Rebbeck TR, et al. Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 645-57. PMID 22351618 DOI: 10.1158/1055-9965.Epi-11-0888  0.76
2012 Antoniou AC, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, McGuffog L, Lee A, Barrowdale D, Healey S, Sinilnikova OM, Caligo MA, Loman N, Harbst K, Lindblom A, Arver B, ... ... Rebbeck T, et al. Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. Breast Cancer Research : Bcr. 14: R33. PMID 22348646 DOI: 10.1186/Bcr3121  0.76
2012 Cabral WA, Barnes AM, Adeyemo A, Cushing K, Chitayat D, Porter FD, Panny SR, Gulamali-Majid F, Tishkoff SA, Rebbeck TR, Gueye SM, Bailey-Wilson JE, Brody LC, Rotimi CN, Marini JC. A founder mutation in LEPRE1 carried by 1.5% of West Africans and 0.4% of African Americans causes lethal recessive osteogenesis imperfecta. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 14: 543-51. PMID 22281939 DOI: 10.1038/Gim.2011.44  0.76
2012 Mavaddat N, Barrowdale D, Andrulis IL, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ, Spurdle A, Robson M, Sherman M, Mulligan AM, Couch FJ, Engel C, McGuffog L, Healey S, ... ... Rebbeck TR, et al. Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 134-47. PMID 22144499 DOI: 10.1158/1055-9965.Epi-11-0775  0.76
2012 Hughes L, Zhu F, Ross E, Gross L, Uzzo RG, Chen DY, Viterbo R, Rebbeck TR, Giri VN. Assessing the clinical role of genetic markers of early-onset prostate cancer among high-risk men enrolled in prostate cancer early detection. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 53-60. PMID 22144497 DOI: 10.1158/1055-9965.EPI-11-0727  0.76
2012 Zeigler-Johnson C, Weber A, Spangler E, Panossian S, Rebbeck TR, Malkowicz SB. Relationship of obesity, androgen receptor genotypes and biochemical failure after radical prostatectomy. The Prostate. 72: 984-90. PMID 22025404 DOI: 10.1002/pros.21503  0.76
2012 Sepe DM, McWilliams T, Chen J, Kershenbaum A, Zhao H, La M, Devidas M, Lange B, Rebbeck TR, Aplenc R. Germline genetic variation and treatment response on CCG-1891. Pediatric Blood & Cancer. 58: 695-700. PMID 21618417 DOI: 10.1182/Blood.V116.21.2711.2711  0.76
2012 Margolis DJ, Mitra N, Sandilands A, McLean I, Rebbeck T. Filaggrin mutations: Prognosis and response to therapy overtime Journal of Investigative Dermatology. 132. DOI: 10.1038/Jid.2012.82  0.76
2012 Kimmel SE, Leufkens HG, Rebbeck TR. Molecular Pharmacoepidemiology Pharmacoepidemiology, Fifth Edition. 601-622. DOI: 10.1002/9781119959946.ch34  0.76
2011 Barnholtz-Sloan JS, Raska P, Rebbeck TR, Millikan RC. Replication of GWAS "Hits" by Race for Breast and Prostate Cancers in European Americans and African Americans. Frontiers in Genetics. 2: 37. PMID 22303333 DOI: 10.3389/Fgene.2011.00037  0.76
2011 Zeigler-Johnson CM, Tierney A, Rebbeck TR, Rundle A. Prostate cancer severity associations with neighborhood deprivation. Prostate Cancer. 2011: 846263. PMID 22111000 DOI: 10.1155/2011/846263  0.44
2011 Healey CS, Ahmed S, O'Mara TA, Ferguson K, Lambrechts D, Garcia-Dios DA, Vergote I, Amant F, Howarth K, Gorman M, Hodgson S, ... ... Rebbeck TR, et al. Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer Study. Carcinogenesis. 32: 1862-6. PMID 21965274 DOI: 10.1093/Carcin/Bgr214  0.44
2011 Cox DG, Simard J, Sinnett D, Hamdi Y, Soucy P, Ouimet M, Barjhoux L, Verny-Pierre C, McGuffog L, Healey S, Szabo C, Greene MH, Mai PL, Andrulis IL, ... ... Rebbeck TR, et al. Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers. Human Molecular Genetics. 20: 4732-47. PMID 21890493 DOI: 10.1093/Hmg/Ddr388  0.76
2011 Chen F, Chen GK, Millikan RC, John EM, Ambrosone CB, Bernstein L, Zheng W, Hu JJ, Ziegler RG, Deming SL, Bandera EV, Nyante S, Palmer JR, Rebbeck TR, Ingles SA, et al. Fine-mapping of breast cancer susceptibility loci characterizes genetic risk in African Americans. Human Molecular Genetics. 20: 4491-503. PMID 21852243 DOI: 10.1093/Hmg/Ddr367  0.76
2011 Rebbeck TR, Mitra N, Domchek SM, Wan F, Friebel TM, Tran TV, Singer CF, Tea MK, Blum JL, Tung N, Olopade OI, Weitzel JN, Lynch HT, Snyder CL, Garber JE, et al. Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes. Cancer Research. 71: 5792-805. PMID 21799032 DOI: 10.1158/0008-5472.Can-11-0773  0.76
2011 Kang G, Gao G, Shete S, Redden DT, Chang BL, Rebbeck TR, Barnholtz-Sloan JS, Pajewski NM, Allison DB. Capitalizing on admixture in genome-wide association studies: a two-stage testing procedure and application to height in African-Americans. Frontiers in Genetics. 2. PMID 21754915 DOI: 10.3389/Fgene.2011.00011  0.76
2011 Neuhausen SL, Brummel S, Ding YC, Steele L, Nathanson KL, Domchek S, Rebbeck TR, Singer CF, Pfeiler G, Lynch HT, Garber JE, Couch F, Weitzel JN, Godwin A, Narod SA, et al. Genetic variation in IGF2 and HTRA1 and breast cancer risk among BRCA1 and BRCA2 carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1690-702. PMID 21708937 DOI: 10.1158/1055-9965.Epi-10-1336  0.76
2011 Taioli E, Flores-Obando RE, Agalliu I, Blanchet P, Bunker CH, Ferrell RE, Jackson M, Kidd LC, Kolb S, Lavender NA, McFarlane-Anderson N, Morrison SS, Multigner L, Ostrande EA, Park JY, ... ... Rebbeck TR, et al. Multi-institutional prostate cancer study of genetic susceptibility in populations of African descent. Carcinogenesis. 32: 1361-5. PMID 21705483 DOI: 10.1093/Carcin/Bgr119  0.76
2011 Haiman CA, Chen GK, Blot WJ, Strom SS, Berndt SI, Kittles RA, Rybicki BA, Isaacs WB, Ingles SA, Stanford JL, Diver WR, Witte JS, Hsing AW, Nemesure B, Rebbeck TR, et al. Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nature Genetics. 43: 570-3. PMID 21602798 DOI: 10.1038/Ng.839  0.76
2011 Im KM, Kirchhoff T, Wang X, Green T, Chow CY, Vijai J, Korn J, Gaudet MM, Fredericksen Z, Shane Pankratz V, Guiducci C, Crenshaw A, McGuffog L, Kartsonaki C, Morrison J, ... ... Rebbeck TR, et al. Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers. Human Genetics. 130: 685-99. PMID 21597964 DOI: 10.1007/S00439-011-1003-Z  0.76
2011 Antoniou AC, Kartsonaki C, Sinilnikova OM, Soucy P, McGuffog L, Healey S, Lee A, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Cattaneo E, Barile M, Pensotti V, Pasini B, ... ... Rebbeck T, et al. Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers. Human Molecular Genetics. 20: 3304-21. PMID 21593217 DOI: 10.1093/Hmg/Ddr226  0.76
2011 Catalona WJ, Bailey-Wilson JE, Camp NJ, Chanock SJ, Cooney KA, Easton DF, Eeles RA, FitzGerald LM, Freedman ML, Gudmundsson J, Kittles RA, Margulies EH, McGuire BB, Ostrander EA, Rebbeck TR, et al. National Cancer Institute Prostate Cancer Genetics Workshop. Cancer Research. 71: 3442-6. PMID 21558387 DOI: 10.1158/0008-5472.Can-11-0314  0.76
2011 Margolis DJ, Papadopoulos M, Apter AJ, McLean WH, Mitra N, Rebbeck TR. Obtaining DNA in the mail from a national sample of children with a chronic non-fatal illness. The Journal of Investigative Dermatology. 131: 1765-7. PMID 21509047 DOI: 10.1038/Jid.2011.102  0.76
2011 Barnholtz-Sloan JS, Guan X, Zeigler-Johnson C, Meropol NJ, Rebbeck TR. Decision tree-based modeling of androgen pathway genes and prostate cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1146-55. PMID 21493872 DOI: 10.1158/1055-9965.Epi-10-0996  0.76
2011 Martrat G, Maxwell CM, Tominaga E, Porta-de-la-Riva M, Bonifaci N, Gómez-Baldó L, Bogliolo M, Lázaro C, Blanco I, Brunet J, Aguilar H, Fernández-Rodríguez J, Seal S, Renwick A, Rahman N, ... ... Rebbeck TR, et al. Exploring the link between MORF4L1 and risk of breast cancer. Breast Cancer Research : Bcr. 13: R40. PMID 21466675 DOI: 10.1186/Bcr2862  0.76
2011 Rebbeck TR. Where were you in November 1991? Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 567-8. PMID 21454416 DOI: 10.1158/1055-9965.EPI-11-0182  0.76
2011 Osorio A, Milne RL, Alonso R, Pita G, Peterlongo P, Teulé A, Nathanson KL, Domchek SM, Rebbeck T, Lasa A, Konstantopoulou I, Hogervorst FB, Verhoef S, van Dooren MF, Jager A, et al. Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2. British Journal of Cancer. 104: 1356-61. PMID 21427728 DOI: 10.1038/Bjc.2011.91  0.76
2011 Spurdle AB, Marquart L, McGuffog L, Healey S, Sinilnikova O, Wan F, Chen X, Beesley J, Singer CF, Dressler AC, Gschwantler-Kaulich D, Blum JL, Tung N, Weitzel J, Lynch H, ... ... Rebbeck TR, et al. Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1032-8. PMID 21393566 DOI: 10.1158/1055-9965.Epi-10-0909  0.76
2011 Lurie G, Gaudet MM, Spurdle AB, Carney ME, Wilkens LR, Yang HP, Weiss NS, Webb PM, Thompson PJ, Terada K, Setiawan VW, Rebbeck TR, Prescott J, Orlow I, O'Mara T, et al. The obesity-associated polymorphisms FTO rs9939609 and MC4R rs17782313 and endometrial cancer risk in non-Hispanic white women. Plos One. 6: e16756. PMID 21347432 DOI: 10.1371/Journal.Pone.0016756  0.76
2011 Stefflova K, Dulik MC, Barnholtz-Sloan JS, Pai AA, Walker AH, Rebbeck TR. Dissecting the within-Africa ancestry of populations of African descent in the Americas. Plos One. 6: e14495. PMID 21253579 DOI: 10.1371/Journal.Pone.0014495  0.76
2011 Mao JJ, Su HI, Feng R, Donelson ML, Aplenc R, Rebbeck TR, Stanczyk F, DeMichele A. Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors. Breast Cancer Research : Bcr. 13: R8. PMID 21251330 DOI: 10.1186/Bcr2813  0.76
2011 Chang BL, Spangler E, Gallagher S, Haiman CA, Henderson B, Isaacs W, Benford ML, Kidd LR, Cooney K, Strom S, Ingles SA, Stern MC, Corral R, Joshi AD, Xu J, ... ... Rebbeck TR, et al. Validation of genome-wide prostate cancer associations in men of African descent. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 23-32. PMID 21071540 DOI: 10.1158/1055-9965.Epi-10-0698  0.76
2011 Giri VN, Ruth K, Hughes L, Uzzo RG, Chen DY, Boorjian SA, Viterbo R, Rebbeck TR. Racial differences in prediction of time to prostate cancer diagnosis in a prospective screening cohort of high-risk men: effect of TMPRSS2 Met160Val. Bju International. 107: 466-70. PMID 20735386 DOI: 10.1111/j.1464-410X.2010.09522.x  0.76
2011 Barnholtz-Sloan JS, Guan X, Zeigler-Johnson C, Meropol NJ, Rebbeck T. Abstract 2740: Decision tree-based modeling of androgen pathway genes and prostate cancer risk Cancer Research. 71: 2740-2740. DOI: 10.1158/1538-7445.Am2011-2740  0.36
2011 Lynch S, Tenhave T, Spangler E, Walker A, Zeigler-Johnson C, Rebbeck T. Abstract 1896: Simple mediation analysis to determine if MSMB is a prostate specific antigen (PSA) or prostate cancer (PC) gene Cancer Research. 71: 1896-1896. DOI: 10.1158/1538-7445.Am2011-1896  0.44
2011 Zeigler-Johnson CM, Gueye SM, Rebbeck TR. Building infrastructure for cancer research in Africa Journal Africain Du Cancer. 3: 52-58. DOI: 10.1007/s12558-010-0112-2  0.76
2010 Domchek SM, Rebbeck TR. Preventive surgery is associated with reduced cancer risk and mortality in women with BRCA1 and BRCA2 mutations. Ldi Issue Brief. 16: 1-4. PMID 21545057  0.76
2010 Antoniou AC, Beesley J, McGuffog L, Sinilnikova OM, Healey S, Neuhausen SL, Ding YC, Rebbeck TR, Weitzel JN, Lynch HT, Isaacs C, Ganz PA, Tomlinson G, Olopade OI, Couch FJ, et al. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Research. 70: 9742-54. PMID 21118973 DOI: 10.1158/0008-5472.Can-10-1907  0.76
2010 Walker LC, Fredericksen ZS, Wang X, Tarrell R, Pankratz VS, Lindor NM, Beesley J, Healey S, Chen X, Stoppa-Lyonnet D, Tirapo C, Giraud S, Mazoyer S, Muller D, ... ... Rebbeck T, et al. Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers. Breast Cancer Research : Bcr. 12: R102. PMID 21114847 DOI: 10.1186/Bcr2785  0.76
2010 Gaudet MM, Kirchhoff T, Green T, Vijai J, Korn JM, Guiducci C, Segrè AV, McGee K, McGuffog L, Kartsonaki C, Morrison J, Healey S, Sinilnikova OM, Stoppa-Lyonnet D, Mazoyer S, ... ... Rebbeck T, et al. Common genetic variants and modification of penetrance of BRCA2-associated breast cancer. Plos Genetics. 6: e1001183. PMID 21060860 DOI: 10.1371/Journal.Pgen.1001183  0.76
2010 Engel C, Versmold B, Wappenschmidt B, Simard J, Easton DF, Peock S, Cook M, Oliver C, Frost D, Mayes R, Evans DG, Eeles R, Paterson J, Brewer C, ... ... Rebbeck TR, et al. Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 2859-68. PMID 20978178 DOI: 10.1158/1055-9965.Epi-10-0517  0.76
2010 Antoniou AC, Wang X, Fredericksen ZS, McGuffog L, Tarrell R, Sinilnikova OM, Healey S, Morrison J, Kartsonaki C, Lesnick T, Ghoussaini M, Barrowdale D, Peock S, Cook M, ... ... Rebbeck T, et al. A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nature Genetics. 42: 885-92. PMID 20852631 DOI: 10.1038/Ng.669  0.76
2010 Rebbeck TR, Weber AL, Walker AH, Stefflova K, Tran TV, Spangler E, Chang BL, Zeigler-Johnson CM. Context-dependent effects of genome-wide association study genotypes and macroenvironment on time to biochemical (prostate specific antigen) failure after prostatectomy. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 2115-23. PMID 20826827 DOI: 10.1158/1055-9965.Epi-10-0173  0.76
2010 Domchek SM, Friebel TM, Singer CF, Gareth Evans D, Lynch HT, Isaacs C, Garber JE, Neuhausen SL, Matloff E, Eeles R, Pichert G, Van T'veer L, Tung N, Weitzel JN, Couch FJ, ... ... Rebbeck TR, et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality Jama - Journal of the American Medical Association. 304: 967-975. PMID 20810374 DOI: 10.1001/Jama.2010.1237  0.76
2010 Rebbeck TR, Su HI, Sammel MD, Lin H, Tran TV, Gracia CR, Freeman EW. Effect of hormone metabolism genotypes on steroid hormone levels and menopausal symptoms in a prospective population-based cohort of women experiencing the menopausal transition. Menopause (New York, N.Y.). 17: 1026-34. PMID 20505544 DOI: 10.1097/Gme.0B013E3181Db61A1  0.76
2010 Mavaddat N, Rebbeck TR, Lakhani SR, Easton DF, Antoniou AC. Incorporating tumour pathology information into breast cancer risk prediction algorithms. Breast Cancer Research : Bcr. 12: R28. PMID 20482762 DOI: 10.1186/bcr2576  0.76
2010 Gor PP, Su HI, Gray RJ, Gimotty PA, Horn M, Aplenc R, Vaughan WP, Tallman MS, Rebbeck TR, DeMichele A. Cyclophosphamide-metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a retrospective cohort study. Breast Cancer Research : Bcr. 12: R26. PMID 20459744 DOI: 10.1186/Bcr2570  0.76
2010 Rebbeck TR, Paskett E, Sellers TA. Fostering transdisciplinary science Cancer Epidemiology Biomarkers and Prevention. 19: 1149-1150. PMID 20447911 DOI: 10.1158/1055-9965.Epi-10-0266  0.76
2010 Wang X, Pankratz VS, Fredericksen Z, Tarrell R, Karaus M, McGuffog L, Pharaoh PD, Ponder BA, Dunning AM, Peock S, Cook M, Oliver C, Frost D, Sinilnikova OM, ... ... Rebbeck TR, et al. Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Human Molecular Genetics. 19: 2886-97. PMID 20418484 DOI: 10.1093/Hmg/Ddq174  0.76
2010 Moorman PG, Iversen ES, Marcom PK, Marks JR, Wang F, Lee E, Ursin G, Rebbeck TR, Domchek SM, Arun B, Susswein L, Isaacs C, Garber JE, Visvanathan K, et al. Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis. Breast Cancer Research and Treatment. 124: 441-51. PMID 20309627 DOI: 10.1007/S10549-010-0842-Y  0.76
2010 Kanetsky PA, Panossian S, Elder DE, Guerry D, Ming ME, Schuchter L, Rebbeck TR. Does MC1R genotype convey information about melanoma risk beyond risk phenotypes? Cancer. 116: 2416-2428. PMID 20301115 DOI: 10.1002/cncr.24994  0.76
2010 Domchek SM, Friebel TM, Garber JE, Isaacs C, Matloff E, Eeles R, Evans DG, Rubinstein W, Singer CF, Rubin S, Lynch HT, Daly MB, Weitzel J, Ganz PA, Pichert G, ... ... Rebbeck TR, et al. Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers Breast Cancer Research and Treatment. 124: 195-203. PMID 20180014 DOI: 10.1007/S10549-010-0799-X  0.76
2010 Anderson CA, Bellamy S, Figures M, Zeigler-Johnson C, Jalloh M, Spangler E, Coomes M, Gueye S, Rebbeck TR. Dietary intake of Senegalese adults. Nutrition Journal. 9: 7. PMID 20167099 DOI: 10.1186/1475-2891-9-7  0.76
2010 Zeigler‐Johnson CM, Chang B, Panossian S, Spangler E, Malkowicz SB, Rebbeck T. Abstract B122: Multi‐SNP analysis of one‐carbon metabolism genes and prostate cancer outcomes Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-B122  0.44
2010 Zeigler-Johnson CM, Liu Z, Spangler E, Rebbeck T. Abstract B69: Effects of obesity and neighborhood socioeconomic status on prostate cancer stage and grade Cancer Epidemiology, Biomarkers & Prevention. 19. DOI: 10.1158/1055-9965.Disp-10-B69  0.44
2010 Domchek SM, Friebel TM, Rebbeck TR. Association of risk-reducing surgery with cancer risks and mortality in BRCA mutation carriers-reply Jama - Journal of the American Medical Association. 304: 2695-2696. DOI: 10.1001/jama.2010.1855  0.76
2009 Rebbeck TR. A special issue on tobacco Cancer Epidemiology Biomarkers and Prevention. 18: 3139. PMID 19959670 DOI: 10.1158/1055-9965.EPI-09-1169  0.76
2009 Stefflova K, Dulik MC, Pai AA, Walker AH, Zeigler-Johnson CM, Gueye SM, Schurr TG, Rebbeck TR. Evaluation of group genetic ancestry of populations from Philadelphia and Dakar in the context of sex-biased admixture in the Americas. Plos One. 4: e7842. PMID 19946364 DOI: 10.1371/Journal.Pone.0007842  0.76
2009 Neuhausen SL, Brummel S, Ding YC, Singer CF, Pfeiler G, Lynch HT, Nathanson KL, Rebbeck TR, Garber JE, Couch F, Weitzel J, Narod SA, Ganz PA, Daly MB, Godwin AK, et al. Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers. Breast Cancer Research : Bcr. 11: R76. PMID 19843326 DOI: 10.1186/Bcr2414  0.76
2009 Eeles RA, Kote-Jarai Z, Al Olama AA, Giles GG, Guy M, Severi G, Muir K, Hopper JL, Henderson BE, Haiman CA, Schleutker J, Hamdy FC, Neal DE, Donovan JL, Stanford JL, ... ... Rebbeck TR, et al. Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nature Genetics. 41: 1116-21. PMID 19767753 DOI: 10.1038/Ng.450  0.76
2009 Shields PG, Sellers TA, Rebbeck TR. Null results in brief: meeting a need in changing times. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 2347. PMID 19723914 DOI: 10.1158/1055-9965.Epi-09-0684  0.76
2009 Rebbeck TR, Mitra N, Domchek SM, Wan F, Chuai S, Friebel TM, Panossian S, Spurdle A, Chenevix-Trench G, Singer CF, Pfeiler G, Neuhausen SL, Lynch HT, Garber JE, et al. Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers. Cancer Research. 69: 5801-10. PMID 19584272 DOI: 10.1158/0008-5472.Can-09-0625  0.76
2009 Khoury MJ, Bertram L, Boffetta P, Butterworth AS, Chanock SJ, Dolan SM, Fortier I, Garcia-Closas M, Gwinn M, Higgins JP, Janssens AC, Ostell J, Owen RP, Pagon RA, Rebbeck TR, et al. Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases. American Journal of Epidemiology. 170: 269-79. PMID 19498075 DOI: 10.1093/aje/kwp119  0.76
2009 Kang HJ, Feng Z, Sun Y, Atwal G, Murphy ME, Rebbeck TR, Rosenwaks Z, Levine AJ, Hu W. Single-nucleotide polymorphisms in the p53 pathway regulate fertility in humans. Proceedings of the National Academy of Sciences of the United States of America. 106: 9761-6. PMID 19470478 DOI: 10.1073/pnas.0904280106  0.76
2009 Chang YM, Barrett JH, Bishop DT, Armstrong BK, Bataille V, Bergman W, Berwick M, Bracci PM, Elwood JM, Ernstoff MS, Gallagher RP, Green AC, Gruis NA, Holly EA, Ingvar C, ... ... Rebbeck TR, et al. Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls. International Journal of Epidemiology. 38: 814-30. PMID 19359257 DOI: 10.1093/ije/dyp166  0.76
2009 Zhao H, Rebbeck TR, Mitra N. A propensity score approach to correction for bias due to population stratification using genetic and non-genetic factors. Genetic Epidemiology. 33: 679-90. PMID 19353632 DOI: 10.1002/Gepi.20419  0.76
2009 Mushlin RA, Gallagher S, Kershenbaum A, Rebbeck TR. Clique-finding for heterogeneity and multidimensionality in biomarker epidemiology research: the CHAMBER algorithm. Plos One. 4: e4862. PMID 19287484 DOI: 10.1371/journal.pone.0004862  0.76
2009 Rebbeck TR, Kauff ND, Domchek SM. Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers Journal of the National Cancer Institute. 101: 80-87. PMID 19141781 DOI: 10.1093/jnci/djn442  0.76
2009 Setiawan VW, Doherty JA, Shu XO, Akbari MR, Chen C, De Vivo I, Demichele A, Garcia-Closas M, Goodman MT, Haiman CA, Hankinson SE, Henderson BE, Horn-Ross PL, Lacey JV, Le Marchand L, ... ... Rebbeck TR, et al. Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 242-7. PMID 19124504 DOI: 10.1158/1055-9965.Epi-08-0689  0.76
2009 Rebbeck TR, DeMichele A, Tran TV, Panossian S, Bunin GR, Troxel AB, Strom BL. Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women. Carcinogenesis. 30: 269-74. PMID 19028704 DOI: 10.1093/Carcin/Bgn247  0.76
2009 Chang YM, Newton-Bishop JA, Bishop DT, Armstrong BK, Bataille V, Bergman W, Berwick M, Bracci PM, Elwood JM, Ernstoff MS, Green AC, Gruis NA, Holly EA, Ingvar C, Kanetsky PA, ... ... Rebbeck TR, et al. A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes. International Journal of Cancer. Journal International Du Cancer. 124: 420-8. PMID 18792098 DOI: 10.1002/Ijc.23869  0.76
2009 Rebbeck TR, Antoniou AC, Llopis TC, Nevanlinna H, Aittomäki K, Simard J, Spurdle AB, Couch FJ, Pereira LH, Greene MH, Andrulis IL, Pasche B, Kaklamani V, et al. No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study. Breast Cancer Research and Treatment. 115: 185-92. PMID 18523885 DOI: 10.1007/S10549-008-0064-8  0.76
2009 Apter AJ, Schelleman H, Rebbeck T. Reply Journal of Allergy and Clinical Immunology. 123: 509-510. DOI: 10.1016/J.Jaci.2008.10.059  0.76
2008 Rebbeck TR, Brown PH, Hawk ET, Lerman C, Paskett ED, Sellers TA, Lippman SM. Cancer epidemiology, biomarkers & prevention and cancer prevention research: two journals, a common goal. Cancer Prevention Research (Philadelphia, Pa.). 1: 393-5. PMID 19138984 DOI: 10.1158/1940-6207.Capr-08-0176  0.76
2008 Rebbeck TR, Brown PH, Hawk ET, Lerman C, Paskett ED, Sellers TA, Lippman SM. Cancer epidemiology, biomarkers & prevention, and cancer prevention research: two journals, a common goal. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 2903-5. PMID 18990728 DOI: 10.1158/1055-9965.Epi-08-0888  0.76
2008 Tan YC, Zeigler-Johnson C, Mittal RD, Mandhani A, Mital B, Rebbeck TR, Rennert H. Common 8q24 sequence variations are associated with Asian Indian advanced prostate cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 2431-5. PMID 18768513 DOI: 10.1158/1055-9965.EPI-07-2823  0.76
2008 Rebbeck TR. A note from the new editor-in-chief Cancer Epidemiology Biomarkers and Prevention. 17: 2203-2204. PMID 18768482 DOI: 10.1158/1055-9965.EPI-08-0740  0.76
2008 DeMichele A, Troxel AB, Berlin JA, Weber AL, Bunin GR, Turzo E, Schinnar R, Burgh D, Berlin M, Rubin SC, Rebbeck TR, Strom BL. Impact of raloxifene or tamoxifen use on endometrial cancer risk: a population-based case-control study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 4151-9. PMID 18757329 DOI: 10.1200/Jco.2007.14.0921  0.76
2008 Palma MD, Domchek SM, Stopfer J, Erlichman J, Siegfried JD, Tigges-Cardwell J, Mason BA, Rebbeck TR, Nathanson KL. The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families. Cancer Research. 68: 7006-14. PMID 18703817 DOI: 10.1158/0008-5472.Can-08-0599  0.76
2008 Wei Z, Li M, Rebbeck T, Li H. U-statistics-based tests for multiple genes in genetic association studies. Annals of Human Genetics. 72: 821-33. PMID 18691161 DOI: 10.1111/J.1469-1809.2008.00473.X  0.76
2008 Israni AK, Li N, Cizman BB, Snyder J, Abrams J, Joffe M, Rebbeck T, Feldman HI. Association of donor inflammation- and apoptosis-related genotypes and delayed allograft function after kidney transplantation. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 52: 331-9. PMID 18640487 DOI: 10.1053/J.Ajkd.2008.05.006  0.76
2008 Warnecke RB, Oh A, Breen N, Gehlert S, Paskett E, Tucker KL, Lurie N, Rebbeck T, Goodwin J, Flack J, Srinivasan S, Kerner J, Heurtin-Roberts S, Abeles R, Tyson FL, et al. Approaching health disparities from a population perspective: the National Institutes of Health Centers for Population Health and Health Disparities. American Journal of Public Health. 98: 1608-15. PMID 18633099 DOI: 10.2105/Ajph.2006.102525  0.76
2008 Rebbeck TR, Rennert H, Walker AH, Panossian S, Tran T, Walker K, Spangler E, Patacsil-Coomes M, Sachdeva R, Wein AJ, Malkowicz SB, Zeigler-Johnson C. Joint effects of inflammation and androgen metabolism on prostate cancer severity. International Journal of Cancer. Journal International Du Cancer. 123: 1385-9. PMID 18566991 DOI: 10.1002/ijc.23687  0.76
2008 Apter AJ, Schelleman H, Walker A, Addya K, Rebbeck T. Clinical and genetic risk factors of self-reported penicillin allergy Journal of Allergy and Clinical Immunology. 122: 152-158. PMID 18538381 DOI: 10.1016/J.Jaci.2008.03.037  0.76
2008 Rennert H, Zeigler-Johnson C, Mittal RD, Tan YC, Sadowl CM, Edwards J, Finley MJ, Mandhani A, Mital B, Rebbeck TR. Analysis of the RNASEL/HPC1, and macrophage scavenger receptor 1 in Asian-Indian advanced prostate cancer. Urology. 72: 456-60. PMID 18436282 DOI: 10.1016/j.urology.2007.11.139  0.76
2008 Barnholtz-Sloan JS, McEvoy B, Shriver MD, Rebbeck TR. Ancestry estimation and correction for population stratification in molecular epidemiologic association studies. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 471-7. PMID 18349264 DOI: 10.1158/1055-9965.Epi-07-0491  0.76
2008 Jalloh M, Zeigler-Johnson C, Sylla-Niang M, Niang L, Labou I, Konte KA, Rebbeck TR, Gueye S. A study of PSA values in an unselected sample of Senegalese men. The Canadian Journal of Urology. 15: 3883-5. PMID 18304398  0.76
2008 Zeigler-Johnson CM, Spangler E, Jalloh M, Gueye SM, Rennert H, Rebbeck TR. Genetic susceptibility to prostate cancer in men of African descent: implications for global disparities in incidence and outcomes. The Canadian Journal of Urology. 15: 3872-82. PMID 18304397  0.76
2008 Ioannidis JP, Boffetta P, Little J, O'Brien TR, Uitterlinden AG, Vineis P, Balding DJ, Chokkalingam A, Dolan SM, Flanders WD, Higgins JP, McCarthy MI, McDermott DH, Page GP, Rebbeck TR, et al. Assessment of cumulative evidence on genetic associations: interim guidelines. International Journal of Epidemiology. 37: 120-32. PMID 17898028 DOI: 10.1093/Ije/Dym159  0.76
2008 Rebbeck TR, Domchek SM. Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers Breast Cancer Research. 10. DOI: 10.1186/bcr2115  0.76
2008 Rebbeck T, Troxel AB, Norman S. Pharmacogenetic modulation of combined hormone replacement therapy by progesterone-metabolism genotypes in postmenopausal breast cancer risk (American Journal of Epidemiology (2007) 166, (1392-1399)) American Journal of Epidemiology. 167: 888. DOI: 10.1093/aje/kwn048  0.76
2008 Rebbeck TR, Troxel AB, DeMichele A, Strom BL. Response to Boucher et al International Journal of Cancer. 123: 2467-2468. DOI: 10.1002/Ijc.23766  0.76
2007 DeMichele A, Gimotty P, Botbyl J, Aplenc R, Colligon T, Foulkes AS, Rebbeck TR. In response to "Drug metabolizing enzyme polymorphisms predict clinical outcome in a node-positive breast cancer cohort". Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 5675-7. PMID 18065748 DOI: 10.1200/Jco.2006.10.1485  0.76
2007 Israni AK, Li N, Sidhwani S, Rosas S, Kong X, Joffe M, Rebbeck T, Feldman HI. Association of hypertension genotypes and decline in renal function after kidney transplantation. Transplantation. 84: 1240-7. PMID 18049108 DOI: 10.1097/01.Tp.0000287324.95119.Ae  0.76
2007 Antoniou AC, Sinilnikova OM, Simard J, Léoné M, Dumont M, Neuhausen SL, Struewing JP, Stoppa-Lyonnet D, Barjhoux L, Hughes DJ, Coupier I, Belotti M, Lasset C, Bonadona V, Bignon YJ, ... ... Rebbeck TR, et al. RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. American Journal of Human Genetics. 81: 1186-200. PMID 17999359 DOI: 10.1086/522611  0.76
2007 Spangler E, Zeigler-Johnson CM, Coomes M, Malkowicz SB, Wein A, Rebbeck TR. Association of Obesity With Tumor Characteristics and Treatment Failure of Prostate Cancer in African-American and European American Men Journal of Urology. 178: 1939-1945. PMID 17868722 DOI: 10.1016/j.juro.2007.07.021  0.76
2007 Couch FJ, Sinilnikova O, Vierkant RA, Pankratz VS, Fredericksen ZS, Stoppa-Lyonnet D, Coupier I, Hughes D, Hardouin A, Berthet P, Peock S, Cook M, Baynes C, Hodgson S, Morrison PJ, ... ... Rebbeck TR, et al. AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 1416-21. PMID 17627006 DOI: 10.1158/1055-9965.EPI-07-0129  0.76
2007 Rebbeck TR, Troxel AB, Shatalova EG, Blanchard R, Norman S, Bunin G, Demichele A, Schinnar R, Berlin JA, Strom BL. Lack of effect modification between estrogen metabolism genotypes and combined hormone replacement therapy in postmenopausal breast cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 1318-20. PMID 17548708 DOI: 10.1158/1055-9965.Epi-07-0084  0.76
2007 Rebbeck TR, Khoury MJ, Potter JD. Genetic association studies of cancer: Where do we go from here? Cancer Epidemiology Biomarkers and Prevention. 16: 864-865. PMID 17507606 DOI: 10.1158/1055-9965.Epi-07-0289  0.76
2007 Rebbeck TR, Troxel AB, Walker AH, Panossian S, Gallagher S, Shatalova EG, Blanchard R, Norman S, Bunin G, DeMichele A, Berlin M, Schinnar R, Berlin JA, Strom BL. Pairwise combinations of estrogen metabolism genotypes in postmenopausal breast cancer etiology. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 444-50. PMID 17372239 DOI: 10.1158/1055-9965.Epi-06-0800  0.76
2007 Orlow I, Begg CB, Cotignola J, Roy P, Hummer AJ, Clas BA, Mujumdar U, Canchola R, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, ... ... Rebbeck TR, et al. CDKN2A germline mutations in individuals with cutaneous malignant melanoma. The Journal of Investigative Dermatology. 127: 1234-43. PMID 17218939 DOI: 10.1038/Sj.Jid.5700689  0.76
2007 Domchek SM, Rebbeck TR. Prophylactic oophorectomy in women at increased cancer risk Current Opinion in Obstetrics and Gynecology. 19: 27-30. PMID 17218848 DOI: 10.1097/GCO.0b013e32801195da  0.76
2007 Kricker A, Armstrong BK, Goumas C, Litchfield M, Begg CB, Hummer AJ, Marrett LD, Theis B, Millikan RC, Thomas N, Culver HA, Gallagher RP, Dwyer T, Rebbeck TR, Kanetsky PA, et al. Ambient UV, personal sun exposure and risk of multiple primary melanomas. Cancer Causes & Control : Ccc. 18: 295-304. PMID 17206532 DOI: 10.1007/s10552-006-0091-x  0.76
2007 Rebbeck TR, Troxel AB, Norman S, Bunin GR, DeMichele A, Baumgarten M, Berlin M, Schinnar R, Strom BL. A retrospective case-control study of the use of hormone-related supplements and association with breast cancer. International Journal of Cancer. Journal International Du Cancer. 120: 1523-8. PMID 17205521 DOI: 10.1002/Ijc.22485  0.76
2007 Andreadis C, Gimotty PA, Wahl P, Hammond R, Houldsworth J, Schuster SJ, Rebbeck TR. Members of the glutathione and ABC-transporter families are associated with clinical outcome in patients with diffuse large B-cell lymphoma. Blood. 109: 3409-16. PMID 17179223 DOI: 10.1182/Blood-2006-09-047621  0.76
2007 Friebel TM, Domchek SM, Neuhausen SL, Wagner T, Evans DG, Isaacs C, Garber JE, Daly MB, Eeles R, Matloff E, Tomlinson G, Lynch HT, Tung N, Blum JL, Weitzel J, ... ... Rebbeck TR, et al. Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers Clinical Breast Cancer. 7: 875-882. DOI: 10.3816/CBC.2007.n.053  0.76
2007 Mushlin RA, Kershenbaum A, Gallagher ST, Rebbeck TR. A graph-theoretical approach for pattern discovery in epidemiological research Ibm Systems Journal. 46: 135-149. DOI: 10.1147/sj.461.0135  0.76
2006 Ambrosone CB, Rebbeck TR, Morgan GJ, Albain KS, Calle EE, Evans WE, Hayes DF, Kushi LH, McLeod HL, Rowland JH, Ulrich CM. New developments in the epidemiology of cancer prognosis: Traditional and molecular predictors of treatment response and survival Cancer Epidemiology Biomarkers and Prevention. 15: 2042-2046. PMID 17119026 DOI: 10.1158/1055-9965.Epi-06-0827  0.76
2006 Strom BL, Schinnar R, Weber AL, Bunin G, Berlin JA, Baumgarten M, DeMichele A, Rubin SC, Berlin M, Troxel AB, Rebbeck TR. Case-control study of postmenopausal hormone replacement therapy and endometrial cancer. American Journal of Epidemiology. 164: 775-86. PMID 16997897 DOI: 10.1093/Aje/Kwj316  0.76
2006 Rebbeck TR, Troxel AB, Wang Y, Walker AH, Panossian S, Gallagher S, Shatalova EG, Blanchard R, Bunin G, DeMichele A, Rubin SC, Baumgarten M, Berlin M, Schinnar R, Berlin JA, et al. Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk. Journal of the National Cancer Institute. 98: 1311-20. PMID 16985250 DOI: 10.1093/Jnci/Djj360  0.76
2006 Rebbeck TR. Conquering cancer disparities: New opportunities for cancer epidemiology, biomarker, and prevention research Cancer Epidemiology Biomarkers and Prevention. 15: 1569-1571. PMID 16985011 DOI: 10.1158/1055-9965.EPI-06-0613  0.76
2006 Kanetsky PA, Rebbeck TR, Hummer AJ, Panossian S, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Culver HA, Zanetti R, Gallagher RP, Dwyer T, Busam K, From L, et al. Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma Cancer Research. 66: 9330-9337. PMID 16982779 DOI: 10.1158/0008-5472.Can-06-1634  0.76
2006 Berwick M, Orlow I, Hummer AJ, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Kanetsky PA, Busam K, et al. The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: An international population-based study Cancer Epidemiology Biomarkers and Prevention. 15: 1520-1525. PMID 16896043 DOI: 10.1158/1055-9965.Epi-06-0270  0.76
2006 Rebbeck TR, Halbert CH, Sankar P. Genetics, epidemiology, and cancer disparities: Is it black and white? Journal of Clinical Oncology. 24: 2164-2169. PMID 16682735 DOI: 10.1200/JCO.2005.05.1656  0.76
2006 Rebbeck TR. Inherited genetic markers and cancer outcomes: Personalized medicine in the postgenome era Journal of Clinical Oncology. 24: 1972-1974. PMID 16648495 DOI: 10.1200/JCO.2005.05.1532  0.76
2006 Pierce LJ, Levin AM, Rebbeck TR, Ben-David MA, Friedman E, Solin LJ, Harris EE, Gaffney DK, Haffty BG, Dawson LA, Narod SA, Olivotto IA, Eisen A, Whelan TJ, Olopade OI, et al. Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 2437-43. PMID 16636335 DOI: 10.1200/Jco.2005.02.7888  0.76
2006 Begg C, Hummer AJ, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Busam K, From L, et al. A design for cancer case-control studies using only incident cases: Experience with the GEM study of melanoma International Journal of Epidemiology. 35: 756-764. PMID 16556646 DOI: 10.1093/Ije/Dyl044  0.76
2006 Domchek SM, Stopfer JE, Rebbeck TR. Bilateral risk-reducing oophorectomy in BRCA1 and BRCA2 mutation carriers Jnccn Journal of the National Comprehensive Cancer Network. 4: 177-182. PMID 16451773  0.76
2006 Wang Y, Localio R, Rebbeck TR. Evaluating bias due to population stratification in epidemiologic studies of gene-gene or gene-environment interactions. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 124-32. PMID 16434597 DOI: 10.1158/1055-9965.Epi-05-0304  0.76
2006 Millikan RC, Hummer A, Begg C, Player J, de Cotret AR, Winkel S, Mohrenweiser H, Thomas N, Armstrong B, Kricker A, Marrett LD, Gruber SB, Culver HA, Zanetti R, Gallagher RP, ... ... Rebbeck TR, et al. Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study. Carcinogenesis. 27: 610-8. PMID 16258177 DOI: 10.1093/Carcin/Bgi252  0.76
2006 Colilla S, Kantoff PW, Neuhausen SL, Godwin AK, Daly MB, Narod SA, Garber JE, Lynch HT, Brown M, Weber BL, Rebbeck TR. The joint effect of smoking and AIB1 on breast cancer risk in BRCA1 mutation carriers. Carcinogenesis. 27: 599-605. PMID 16244359 DOI: 10.1093/Carcin/Bgi246  0.76
2006 Kanetsky PA, Rebbeck TR. Low-penetrance genotypes, pigmentation phenotypes, and melanoma etiology From Melanocytes to Melanoma: the Progression to Malignancy. 347-364. DOI: 10.1007/978-1-59259-994-3_19  0.76
2005 Rebbeck TR, Sankar P. Ethnicity, ancestry, and race in molecular epidemiologic research Cancer Epidemiology Biomarkers and Prevention. 14: 2467-2471. PMID 16284364 DOI: 10.1158/1055-9965.EPI-05-0649  0.76
2005 Shatalova EG, Walther SE, Favorova OO, Rebbeck TR, Blanchard RL. Genetic polymorphisms in human SULT1A1 and UGT1A1 genes associate with breast tumor characteristics: a case-series study Breast Cancer Research : Bcr. 7: R909-R921. PMID 16280036  0.76
2005 Begg CB, Orlow I, Hummer AJ, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Mitra N, Busam K, et al. Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample Journal of the National Cancer Institute. 97: 1507-1515. PMID 16234564 DOI: 10.1093/Jnci/Dji312  0.76
2005 Rebbeck TR. Genetics, disparities, and prostate cancer Ldi Issue Brief. 10: 1-4. PMID 16114130  0.76
2005 DeMichele A, Aplenc R, Botbyl J, Colligan T, Wray L, Klein-Cabral M, Foulkes A, Gimotty P, Glick J, Weber B, Stadtmauer E, Rebbeck TR. Drug-metabolizing enzyme polymorphisms predict clinical outcome in a node-positive breast cancer cohort. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 5552-9. PMID 16110016 DOI: 10.1200/Jco.2005.06.208  0.76
2005 Landi MT, Kanetsky PA, Tsang S, Gold B, Munroe D, Rebbeck T, Swoyer J, Ter-Minassian M, Hedayati M, Grossman L, Goldstein AM, Calista D, Pfeiffer RM. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. Journal of the National Cancer Institute. 97: 998-1007. PMID 15998953 DOI: 10.1093/Jnci/Dji176  0.56
2005 Wang Y, Localio R, Rebbeck TR. Bias correction with a single null marker for population stratification in candidate gene association studies. Human Heredity. 59: 165-75. PMID 15920341 DOI: 10.1159/000085940  0.76
2005 Colilla S, Lerman C, Shields PG, Jepson C, Rukstalis M, Berlin J, DeMichele A, Bunin G, Strom BL, Rebbeck TR. Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women. Pharmacogenetics and Genomics. 15: 393-8. PMID 15900212 DOI: 10.1097/01213011-200506000-00004  0.76
2005 Rennert H, Zeigler-Johnson CM, Addya K, Finley MJ, Walker AH, Spangler E, Leonard DG, Wein A, Malkowicz SB, Rebbeck TR. Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 949-57. PMID 15824169 DOI: 10.1158/1055-9965.EPI-04-0637  0.76
2005 Aplenc R, Thompson J, Han P, La M, Zhao H, Lange B, Rebbeck T. Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia. Cancer Research. 65: 2482-7. PMID 15781665 DOI: 10.1158/0008-5472.Can-04-2606  0.76
2005 Spangler E, Zeigler-Johnson CM, Malkowicz SB, Wein AJ, Rebbeck TR. Association of prostate cancer family history with histopathological and clinical characteristics of prostate tumors International Journal of Cancer. 113: 471-474. PMID 15455347 DOI: 10.1002/ijc.20578  0.76
2005 Rebbeck TR. Commentary: Use of hormone replacement therapy after bilateral risk-reducing oophorectomy in BRCA1 and BRCA2 mutation carriers Hereditary Cancer in Clinical Practice. 3: 91-93.  0.76
2004 Rebbeck TR, Martínez ME, Sellers TA, Shields PG, Wild CP, Potter JD. Genetic variation and cancer: improving the environment for publication of association studies. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 13: 1985-6. PMID 15598750  0.76
2004 Begg CB, Hummer A, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Klotz JB, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Berwick MR. Familial aggregation of melanoma risks in a large population-based sample of melanoma cases Cancer Causes and Control. 15: 957-965. PMID 15577298 DOI: 10.1007/S10522-004-2474-2  0.76
2004 Zeigler-Johnson C, Friebel T, Walker AH, Wang Y, Spangler E, Panossian S, Patacsil M, Aplenc R, Wein AJ, Malkowicz SB, Rebbeck TR. CYP3A4, CYP3A5, and CYP3A43 genotypes and haplotypes in the etiology and severity of prostate cancer. Cancer Research. 64: 8461-7. PMID 15548719 DOI: 10.1158/0008-5472.Can-04-1651  0.76
2004 Huang J, Domchek SM, Brose MS, Rebbeck TR, Nathanson KL, Weber BL. Germline CHEK2*1100delC mutations in breast cancer patients with multiple primary cancers Journal of Medical Genetics. 41. PMID 15520402 DOI: 10.1136/Jmg.2004.022913  0.76
2004 Deitz AC, Rothman N, Rebbeck TR, Hayes RB, Chow WH, Zheng W, Hein DW, García-Closas M. Impact of misclassification in genotype-exposure interaction studies: Example of N-acetyltransferase 2 (NAT2), smoking, and bladder cancer Cancer Epidemiology Biomarkers and Prevention. 13: 1543-1546. PMID 15342459  0.76
2004 Rebbeck TR, Spitz M, Wu X. Assessing the function of genetic variants in candidate gene association studies Nature Reviews Genetics. 5: 589-597. PMID 15266341 DOI: 10.1038/Nrg1403  0.76
2004 Wang Y, Localio R, Rebbeck TR. Evaluating bias due to population stratification in case-control association studies of admixed populations. Genetic Epidemiology. 27: 14-20. PMID 15185399 DOI: 10.1002/Gepi.20003  0.76
2004 Kanetsky PA, Ge F, Najarian D, Swoyer J, Panossian S, Schuchter L, Holmes R, Guerry D, Rebbeck TR. Assessment of polymorphic variants in the melanocortin-1 receptor gene with cutaneous pigmentation using an evolutionary approach. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 13: 808-19. PMID 15159314  0.76
2004 Rebbeck TR, Ambrosone CB, Bell DA, Chanock SJ, Hayes RB, Kadlubar FF, Thomas DC. SNPs, Haplotypes, and cancer: Applications in molecular epidemiology Cancer Epidemiology Biomarkers and Prevention. 13: 681-687. PMID 15159297  0.76
2004 Smits KM, Benhamou S, Garte S, Weijenberg MP, Alamanos Y, Ambrosone C, Autrup H, Autrup JL, Baranova H, Bathum L, Boffetta P, Bouchardy C, Brockmoller J, Butkiewicz D, Cascorbi I, ... ... Rebbeck T, et al. Association of metabolic gene polymorphisms with tobacco consumption in healthy controls. International Journal of Cancer. Journal International Du Cancer. 110: 266-70. PMID 15069692 DOI: 10.1002/Ijc.20114  0.76
2004 Rebbeck TR. Biomarkers of inherited susceptibility and cancer Iarc Scientific Publications. 91-103. PMID 15055292  0.76
2003 Amirimani B, Ning B, Deitz AC, Weber BL, Kadlubar FF, Rebbeck TR. Increased Transcriptional Activity of the CYP3A4* 1B Promoter Variant Environmental and Molecular Mutagenesis. 42: 299-305. PMID 14673875 DOI: 10.1002/Em.10199  0.76
2003 Martin AM, Athanasiadis G, Greshock JD, Fisher J, Lux MP, Calzone K, Rebbeck TR, Weber BL. Population frequencies of single nucleotide polymorphisms (SNPs) in immuno-modulatory genes Human Heredity. 55: 171-178. PMID 14566095 DOI: 10.1159/000073201  0.76
2003 Aplenc R, Glatfelter W, Han P, Rappaport E, La M, Cnaan A, Blackwood MA, Lange B, Rebbeck T. CYP3A genotypes and treatment response in paediatric acute lymphoblastic leukaemia. British Journal of Haematology. 122: 240-4. PMID 12846892 DOI: 10.1046/J.1365-2141.2003.04430.X  0.76
2003 Gueye SM, Zeigler-Johnson CM, Friebel T, Spangler E, Jalloh M, MacBride S, Malkowicz SB, Rebbeck TR. Clinical characteristics of prostate cancer in African Americans, American whites, and Senegalese men. Urology. 61: 987-92. PMID 12736021 DOI: 10.1016/S0090-4295(02)02588-8  0.76
2003 Rebbeck TR. Epidemiological approaches to the identification of cancer predisposition genes Methods in Molecular Biology (Clifton, N.J.). 222: 309-325. PMID 12710695  0.76
2003 Martin AM, Kanetsky PA, Amirimani B, Colligon TA, Athanasiadis G, Shih HA, Gerrero MR, Calzone K, Rebbeck TR, Weber BL. Germline TP53 mutations in breast cancer families with multiple primary cancers: is TP53 a modifier of BRCA1? Journal of Medical Genetics. 40. PMID 12676907  0.76
2003 Aplenc R, Zhao H, Rebbeck TR, Propert KJ. Group sequential methods and sample size savings in biomarker-disease association studies. Genetics. 163: 1215-9. PMID 12663557  0.76
2002 Marz JF, Rebbeck TR, Sankar P, Meagher EA. Pilot study: does the white coat influence research participation? Irb; a Review of Human Subjects Research. 24: 6-8. PMID 13678029  0.76
2002 Rebbeck TR. Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers European Journal of Cancer. 38. PMID 12409058 DOI: 10.1016/S0959-8049(02)80012-0  0.76
2002 Rebbeck TR. Inherited genotype and prostate cancer outcomes Cancer Epidemiology Biomarkers and Prevention. 11: 945-952. PMID 12376492  0.76
2002 Brose MS, Rebbeck TR, Calzone KA, Stopfer JE, Nathanson KL, Weber BL. Cancer risk estimates for BCRA1 mutation carriers identified in a risk evaluation program Journal of the National Cancer Institute. 94: 1365-1372. PMID 12237282 DOI: 10.1093/Jnci/94.18.1365  0.76
2002 Acs G, Zhang PJ, Rebbeck TR, Acs P, Verma A. Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma. Cancer. 95: 969-81. PMID 12209679 DOI: 10.1002/cncr.10787  0.76
2002 Aplenc R, Orudjev E, Swoyer J, Manke B, Rebbeck T. Differential bone marrow aspirate DNA yields from commercial extraction kits. Leukemia. 16: 1865-6. PMID 12200706 DOI: 10.1038/Sj.Leu.2402681  0.76
2002 Rebbeck TR, Kanetsky PA, Walker AH, Holmes R, Halpern AC, Schuchter LM, Elder DE, Guerry D. P gene as an inherited biomarker of human eye color. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 11: 782-4. PMID 12163334  0.76
2002 Rebbeck TR. The contribution of inherited genotype to breast cancer Breast Cancer Research. 4: 85-89. PMID 12052249 DOI: 10.1186/bcr430  0.76
2002 Nathanson KL, Shugart YY, Omaruddin R, Szabo C, Goldgar D, Rebbeck TR, Weber BL. CGH-targeted linkage analysis reveals a possible BRCA1 modifier locus on chromosome 5q. Human Molecular Genetics. 11: 1327-32. PMID 12019214 DOI: 10.1093/Hmg/11.11.1327  0.76
2002 Rebbeck TR. Inherited predisposition and breast cancer: Modifiers of BRCA1/2-associated breast cancer risk Environmental and Molecular Mutagenesis. 39: 228-234. PMID 11921193 DOI: 10.1002/em.10050  0.76
2002 Shih HA, Couch FJ, Nathanson KL, Anne Blackwood M, Rebbeck TR, Armstrong KA, Calzone K, Stopfer J, Seal S, Stratton MR, Weber BL. BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic Journal of Clinical Oncology. 20: 994-999. PMID 11844822 DOI: 10.1200/Jco.20.4.994  0.76
2002 Kanetsky PA, Swoyer J, Panossian S, Holmes R, Guerry D, Rebbeck TR. A polymorphism in the agouti signaling protein gene is associated with human pigmentation American Journal of Human Genetics. 70: 770-775. PMID 11833005 DOI: 10.1086/339076  0.76
2001 Rebbeck TR, Wang Y, Kantoff PW, Krithivas K, Neuhausen SL, Godwin AK, Daly MB, Narod SA, Brunet JS, Vesprini D, Garber JE, Lynch HT, Weber BL, Brown M. Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history. Cancer Research. 61: 5420-4. PMID 11454686  0.64
2001 Fisher MJ, Virmani AK, Wu L, Aplenc R, Harper JC, Powell SM, Rebbeck TR, Sidransky D, Gazdar AF, El-Deiry WS. Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 7: 1688-97. PMID 11410508  0.76
2001 Kanetsky PA, Holmes R, Walker A, Najarian D, Swoyer J, Guerry D, Halpern A, Rebbeck TR. Interaction of glutathione S-transferase M1 and T1 genotypes and malignant melanoma Cancer Epidemiology Biomarkers and Prevention. 10: 509-513. PMID 11352862  0.76
2001 Nathanson KL, Omaruddin R, Malkowicz SB, Rebbeck TR. An intronic variant in PTEN is not associated with prostate cancer risk Cancer Epidemiology Biomarkers and Prevention. 10: 277-278. PMID 11303600  0.76
2001 Carlini EJ, Raftogianis RB, Wood TC, Jin F, Zheng W, Rebbeck TR, Weinshilboum RM. Sulfation pharmacogenetics: SULT1A1 and SULT1A2 allele frequencies in Caucasian, Chinese and African-American subjects. Pharmacogenetics. 11: 57-68. PMID 11207031 DOI: 10.1097/00008571-200102000-00007  0.76
2001 Acs G, Lawton TJ, Rebbeck TR, LiVolsi VA, Zhang PJ. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. American Journal of Clinical Pathology. 115: 85-98. PMID 11190811 DOI: 10.1309/FDHX-L92R-BATQ-2GE0  0.76
2001 Turner BC, Krajewski S, Krajewska M, Takayama S, Gumbs AA, Carter D, Rebbeck TR, Haffty BG, Reed JC. BAG-1: A novel biomarker predicting long-term survival in early-stage breast cancer Journal of Clinical Oncology. 19: 992-1000. PMID 11181661  0.76
2001 Lovett BD, Strumberg D, Blair IA, Pang S, Burden DA, Megonigal MD, Rappaport EF, Rebbeck TR, Osheroff N, Pommier YG, Felix CA. Etoposide metabolites enhance DNA topoisomerase II cleavage near leukemia-associated MLL translocation breakpoints. Biochemistry. 40: 1159-70. PMID 11170441 DOI: 10.1021/Bi002361X  0.76
2000 Kelada SN, Kardia SL, Walker AH, Wein AJ, Malkowicz SB, Rebbeck TR. The glutathione S-transferase-mu and -theta genotypes in the etiology of prostate cancer: genotype-environment interactions with smoking. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 9: 1329-34. PMID 11142418  0.76
2000 Shih HA, Nathanson KL, Seal S, Collins N, Stratton MR, Rebbeck TR, Weber BL. BRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancers Clinical Cancer Research. 6: 4259-4264. PMID 11106241  0.76
2000 Delaloge S, Morice P, Chompret A, Lhomme C, Eisen A, Rebbeck TR, Weber BL, Wood WC. Prophylactic surgery: Oophorectomy or adnexectomy? [6] (multiple letters) Journal of Clinical Oncology. 18: 3454-3455. PMID 11013293 DOI: 10.1200/Jco.2000.18.19.3454  0.76
2000 Rebbeck TR, Walker AH, Zeigler-Johnson C, Weisburg S, Martin AM, Nathanson KL, Wein AJ, Malkowicz SB. Association of HPC2/ELAC2 genotypes and prostate cancer. American Journal of Human Genetics. 67: 1014-9. PMID 10986046 DOI: 10.1086/303096  0.76
2000 Eisen A, Rebbeck TR, Wood WC, Weber BL. Prophylactic surgery in women with a hereditary to breast and ovarian cancer Journal of Clinical Oncology. 18: 1980-1995. PMID 10784640 DOI: 10.1200/Jco.2000.18.9.1980  0.76
2000 Rebbeck TR. More about: Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4 [1] Journal of the National Cancer Institute. 92: 76. PMID 10620637  0.76
1999 Walker AH, Najarian D, White DL, Jaffe JF, Kanetsky PA, Rebbeck TR. Collection of genomic DNA by buccal swabs for polymerase chain reaction-based biomarker assays. Environmental Health Perspectives. 107: 517-20. PMID 10378997  0.76
1999 Rebbeck TR, Walker AH, Jaffe JM, White DL, Wein AJ, Malkowicz SB. Glutathione S-transferase-mu (GSTM1) and -theta (GSTT1) genotypes in the etiology of prostate cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 8: 283-7. PMID 10207629  0.76
1999 Loh E, Rebbeck TR, Mahoney PD, DeNofrio D, Swain JL, Holmes EW. Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure Circulation. 99: 1422-1425. PMID 10086964  0.76
1999 Carroll BT, Couch FJ, Rebbeck TR, Weber BL. Polymorphisms in PTEN in breast cancer families Journal of Medical Genetics. 36: 94-96. PMID 10051004 DOI: 10.1136/Jmg.36.2.94  0.76
1999 Rebbeck TR. Inherited genetic predisposition in breast cancer: A population-based perspective Cancer. 86: 1673-1681.  0.76
1998 Walker AH, Jaffe JM, Gunasegaram S, Cummings SA, Huang CS, Chern HD, Olopade OI, Weber BL, Rebbeck TR. Characterization of an allelic variant in the nifedipine-specific element of CYP3A4: ethnic distribution and implications for prostate cancer risk. Mutations in brief no. 191. Online. Human Mutation. 12: 289. PMID 10660343  0.76
1998 Rebbeck TR, Rogatko A, Viana MAG. Evaluation of genotype data in clinical risk assessment: Methods and application to BRCA1, BRCA2, and N-acetyl transferase-2 genotypes in breast cancer Genetic Testing. 1: 157-164. PMID 10464641  0.76
1998 Margolis DJ, Halpern AC, Rebbeck T, Schuchter L, Barnhill RL, Fine J, Berwick M. Validation of a melanoma prognostic model. Archives of Dermatology. 134: 1597-601. PMID 9875200 DOI: 10.1001/Archderm.134.12.1597  0.76
1998 Felix CA, Walker AH, Lange BJ, Williams TM, Winick NJ, Cheung NK, Lovett BD, Nowell PC, Blair IA, Rebbeck TR. Association of CYP3A4 genotype with treatment-related leukemia. Proceedings of the National Academy of Sciences of the United States of America. 95: 13176-81. PMID 9789061 DOI: 10.1073/Pnas.95.22.13176  0.76
1998 Arepally G, Rebbeck TR, Song W, Gilliland G, Maris JM, Poncz M. Evidence for genetic homogeneity in a familial platelet disorder with predisposition to acute myelogenous leukemia (FPD/AML) [8] Blood. 92: 2600-2601. PMID 9746808  0.76
1998 Rebbeck TR, Jaffe JM, Walker AH, Wein AJ, Malkowicz SB. Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. Journal of the National Cancer Institute. 90: 1225-9. PMID 9719084  0.76
1998 Felix CA, Hosler MR, Slater DJ, Parker RI, Masterson M, Whitlock JA, Rebbeck TR, Nowell PC, Lange BJ. MLL genomic breakpoint distribution within the breakpoint cluster region in de novo leukemia in children Journal of Pediatric Hematology/Oncology. 20: 299-308. PMID 9703001 DOI: 10.1097/00043426-199807000-00004  0.76
1998 Wang-Gohrke S, Rebbeck TR, Besenfelder W, Kreienberg R, Runnebaum IB. P53 germline polymorphisms are associated with an increased risk for breast cancer in German women Anticancer Research. 18: 2095-2099. PMID 9677474  0.76
1998 Brunet JS, Ghadirian P, Rebbeck TR, Lerman C, Garber JE, Tonin PN, Abrahamson J, Foulkes WD, Daly M, Wagner-Costalas J, Godwin A, Olopade OI, Moslehi R, Liede A, Futreal PA, et al. Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes. Journal of the National Cancer Institute. 90: 761-6. PMID 9605646 DOI: 10.1093/Jnci/90.10.761  0.76
1998 Rubin SC, Blackwood MA, Bandera C, Behbakht K, Benjamin I, Rebbeck TR, Boyd J. BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testing. American Journal of Obstetrics and Gynecology. 178: 670-7. PMID 9579428 DOI: 10.1016/S0002-9378(98)70476-4  0.76
1998 Viana MAG, Rogatko A, Rebbeck TR. Statistical assessment of multivalued screening tests Canadian Journal of Statistics. 26: 657-668.  0.76
1997 Maris JM, Kyemba SM, Rebbeck TR, White PS, Sulman EP, Jensen SJ, Allen C, Biegel JA, Brodeur GM. Molecular genetic analysis of familial neuroblastoma. European Journal of Cancer (Oxford, England : 1990). 33: 1923-8. PMID 9516825 DOI: 10.1016/S0959-8049(97)00265-7  0.76
1997 Pellegrino JE, George RA, Biegel J, Farlow MR, Gardner K, Caress J, Brown MJ, Rebbeck TR, Bird TD, Chance PF. Hereditary neuralgic amyotrophy: evidence for genetic homogeneity and mapping to chromosome 17q25. Human Genetics. 101: 277-83. PMID 9439655 DOI: 10.1007/S004390050629  0.76
1997 Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility Cancer Epidemiology Biomarkers and Prevention. 6: 733-743. PMID 9298582  0.76
1997 Rebbeck TR, Jordan HA, Schnur RE, Rogatko A. Utility of linked markers in genetic counseling: estimation of carrier risks in X-linked ocular albinism. American Journal of Medical Genetics. 70: 58-66. PMID 9129743 DOI: 10.1002/(SICI)1096-8628(19970502)70:1<58::AID-AJMG12>3.0.CO;2-W  0.76
1997 Rebbeck TR, Walker AH, Phelan CM, Godwin AK, Buetow KH, Garber JE, Narod SA, Weber BL. Defining etiologic heterogeneity in breast cancer using genetic biomarkers. Progress in Clinical and Biological Research. 396: 53-61. PMID 9108589  0.76
1996 Rebbeck TR, Godwin AK, Buetow KH. Variability in loss of constitutional heterozygosity across loci and among individuals: Association with candidate genes in ductal breast carcinoma Molecular Carcinogenesis. 17: 117-125. PMID 8944071 DOI: 10.1002/(Sici)1098-2744(199611)17:3<117::Aid-Mc3>3.0.Co;2-C  0.76
1996 Pellegrino JE, Rebbeck TR, Brown MJ, Bird TD, Chance PF. Mapping of hereditary neuralgic amyotrophy (familial brachial plexus neuropathy) to distal chromosome 17q. Neurology. 46: 1128-32. PMID 8780104 DOI: 10.1212/Wnl.46.4.1128  0.76
1996 Rebbeck TR, Turner ST, Sing CF. Probability of having hypertension: Effects of sex, history of hypertension in parents, and other risk factors Journal of Clinical Epidemiology. 49: 727-734. PMID 8691221 DOI: 10.1016/0895-4356(96)00015-7  0.76
1995 Rogatko A, Rebbeck T, Zacks S. Risk prediction with linked markers: Pedigree analysis American Journal of Medical Genetics. 59: 24-32. PMID 8849005 DOI: 10.1002/Ajmg.1320590106  0.76
1995 Lustbader ED, Rebbeck TR, Buetow KH. Using loss of heterozygosity data in affected pedigree member linkage tests Genetic Epidemiology. 12: 339-350. PMID 8536951 DOI: 10.1002/gepi.1370120402  0.76
1995 Hoskins KF, Stopfer JE, Calzone KA, Weber BL, Merajver SD, Rebbeck TR, Garber JE. Assessment and Counseling for Women With a Family History of Breast Cancer: A Guide for Clinicians Jama: the Journal of the American Medical Association. 273: 577-585. PMID 7837392 DOI: 10.1001/Jama.1995.03520310075033  0.76
1994 Rebbeck TR, Rosvold EA, Duggan DJ, Zhang J, Buetow KH. Genetics of CYP1A1: Coamplification of Specific Alleles by Polymerase Chain Reaction and Association with Breast Cancer Cancer Epidemiology Biomarkers and Prevention. 3: 511-514. PMID 8000303  0.76
1994 Schnur RE, Wick PA, Bailey C, Rebbeck T, Weleber RG, Wagstaff J, Grix AW, Pagon RA, Hockey A, Edwards MJ. Phenotypic variability in X-linked ocular albinism: Relationship to linkage genotypes American Journal of Human Genetics. 55: 484-496. PMID 7915878  0.76
1994 Rebbeck TR, Lustbader ED, Buetow KH. Somatic allele loss in genetic linkage analysis of cancer Genetic Epidemiology. 11: 419-429. PMID 7835688 DOI: 10.1002/gepi.1370110504  0.76
1993 Rebbeck TR, Turner ST, Sing CF. Sodium-lithium countertransport genotype and the probability of hypertension in adults Hypertension. 22: 560-568. PMID 8406661 DOI: 10.1161/01.Hyp.22.4.560  0.76
1993 Rebbeck TR, Dietz FR, Murray JC, Buetow KH. A single-gene explanation for the probability of having idiopathic talipes equinovarus American Journal of Human Genetics. 53: 1051-1063. PMID 8213831  0.76
1992 Turner ST, Rebbeck TR, Sing CF. Sodium-lithium countertransport and probability of hypertension in caucasians 47 to 89 years old Hypertension. 20: 841-850. PMID 1452301  0.76
1991 Rebbeck TR, Turner ST, Michels VV, Moll PP. Genetic and environmental explanations for the distribution of sodium-lithium countertransport in pedigrees from Rochester, MN. American Journal of Human Genetics. 48: 1092-104. PMID 2035530  0.76
Show low-probability matches.